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DEVELOPING DROPLET BASED 3D CELL CULTURE METHODS TO
ENABLE INVESTIGATIONS OF THE CHEMICAL TUMOR
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ABSTRACT

Adaptation of cancer cells to changes in the biochemical microenvironment
in an expanding tumor mass is a crucial aspect of malignant progression, tumor
metabolism, and drug efficacy. In vitro, it is challenging to mimic the evolution of
biochemical gradients and the cellular heterogeneity that characterizes cancer
tissues found in vivo. It is well accepted that more realistic and controllable in vitro
3D model systems are required to improve the overall cancer research paradigm
and thus improve on the translation of results, but multidisciplinary approaches are
needed for these advances. This work develops such approaches and
demonstrates that new droplet-based cell-encapsulation techniques have the
ability to encapsulate cancer cells in droplets for standardized and more realistic
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3D cell culture and cancer biology applications. Three individual droplet generating
platforms have been designed and optimized for droplet-based cell encapsulation.
Each has its own advancements and challenges. Together, however, these
technologies

accomplish

droplets/second

to

25,000

medium

to

high-throughput

droplets/second)

of

generation

biomaterial

droplets

(10
for

encapsulation of a range of cell occupancies (5 cells/droplet to 400 cells/droplet).
The data presented also demonstrates the controlled generation of cell-sized small
droplets for biomolecule compartmentalization, droplets with diameters ranging
between 100-400 µm depending on device parameters, and the generation of
instant spheroids. Standardized assays for analyzing cells grown within these new
3D environments include proliferation assays of cells grown in mono- and cocultures, the generation of large and uniform populations of scaffold supported
multicellular spheroids, and a new system for culturing encapsulated cells in
altered environmental conditions.
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Chapter 1

Tools for 3D Cell Culture in Cancer Research

1

1.1

Motivation for the Dissertation

Droplet based cell culture has the potential to become integrated into standard
lab practices as a robust and reliable 3D cell culture platform. Use of these
techniques will enable relevant studies of the heterogeneity within the tumor
microenvironment.

The use of animal modeling, 2D cell culture, preestablished 3D culturing
methods, and mathematical modeling has facilitated many pioneering studies and
overall advancements in understanding the fundamental aspects of the tumor
microenvironment.1 However there is a need and opportunity for the development
of manipulable, multivariable model systems that better mimic, control, and
measure cellular and chemical heterogeneities in the tumor microenvironment.
Using droplet-based cell encapsulation as the foundation for these types of in vitro
multivariable model systems provides a platform to investigate cellular behavior in
a more complex yet controllable environment. The over-arching motivation of
this dissertation is that improvement in droplet-based cell encapsulation
techniques will enable more controllable and realistic investigations of the
heterogeneous environments in which cancer develops.
The main scope of this dissertation is the design and implementation of
droplet generating technologies for cell encapsulation and the development of
standardized cancer biology applications. Although the actual investigation of a
specific biomedical question and hypothesis is out of the scope of this dissertation,

2

it is worth mentioning that the 3D cell culture technologies designed herein are
applicable to biomedical hypotheses that concern topics such as the generation of
cellular and biochemical heterogeneities within the tumor microenvironment. The
content within this dissertation begins the development of standardized 3D cell
culture methods to evaluate tumor cell proliferation and survival in combinatorial
acidic/hypoxic microenvironmental conditions. Eventually, cells cultured in 3D
droplet-based and altered biochemical environments will enable the investigation
of the changes in cellular expression patterns that could arise as mediated by
different transcription factors, such as HIF-1α (hypoxia inducible factor-1α).
The remainder of Chapter 1 provides the biological motivation for the
development of improved 3D cell culture techniques and methodology by focusing
on: the principles of evolutionary biology applied to cancer therapy efficacy
(Section 1.2); the generation of biochemical and cellular heterogeneities (Section
1.3); the biology of hypoxia in the tumor microenvironment (Section 1.4); regulation
of the hypoxia inducible factor pathway by oxygen (Section 1.5); and the potential
influence of pH and metabolism on HIF-1α (Section 1.6). The interaction of these
topics provides an exemplary biomedical system that would be well suited to be
addressed using the improved 3D in vitro approaches described by this
dissertation, which will eventually enable controlled studies of HIF-1α mediated
responses to both coupled and uncoupled variations of hypoxia and acidosis.2,3
The development of droplet-based cell encapsulating technologies as well
as the standardized cancer biology applications that validate the developed
technologies is achieved through two Specific Aims:

3

Specific Aim 1: Development and implementation of droplet generation
technologies for cell encapsulation
Droplet generating instrumentation and methodology has been developed and
demonstrated to encapsulate cells for 3D cell culture. Chapters 3, 4, and 5 each
describes a unique approach for droplet-based cell encapsulation. Specifically,
high-throughput droplet generation in the air is addressed in Chapter 3, microfluidic
droplet generation using loudspeaker acoustics and water-in-water emulsion
chemistries is addressed in Chapter 4, and centrifugal droplet generation for mass
production of cell encapsulating droplets is described in Chapter 5. In each
technology

development

chapter,

flow

rate

measurements,

parameter

optimizations, and overall system implementations are discussed. Droplet
populations are evaluated using microscopy and image processing to determine
the average diameter of the populations. The metric of droplet diameter serves as
a benchmark for the success or improvement of the droplet generating technology.
Generally speaking, these developments in droplet generating technologies make
advancements in multidisciplinary fields in terms of overall cost, simplicity of device
fabrication, high throughput operation, monodispersity, biocompatibility, recovery
of intact cells, and overall robustness of the platforms.
Specific Aim 2: Development of standardized biological assays to measure
droplet-based 3D cell cultures
Cancer research applications are being developed to measure qualities of cells
that have been encapsulated and grown (using the approaches described in
Chapters 3-5). Chapter 6 focuses on the development, implementation, and in
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some cases challenges of biological assays including proliferation assays in 2D vs
3D cell mono- and co-cultures, the formation of multicellular tumor spheroids either
instantly by initial high cell loading in droplets or over time with initial low cell
loading, and the establishment of 3D culture systems with altered biochemical
microenvironments. In general, droplet populations are evaluated with the
methods described in Specific Aim 1. Cell populations encapsulated in droplets
are measured by dissolving the droplet scaffolding material, isolating the cell
population, and analyzing the cells by cell counting and flow cytometry. Chapter 7
concludes the dissertation with a discussion on droplet-based technologies for the
investigation of biomedical questions including challenges to be overcome and
future directions.
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1.2

Heterogeneity in the Tumor Microenvironment and Therapy Efficacy

Principles from evolutionary biology describe why tumor heterogeneity directly
impacts the success of therapeutic interventions.

Cancer is initiated by hyperplasia or uncontrolled reproduction of cells in the
microenvironment, driving the development of malignancies affecting millions of
individuals worldwide.4 The economic and social impact of cancer is significant and
increasing despite the money and efforts directed at eradication and control over
advanced disease states; in 2010 the disease cost approximately US$ 1.16 trillion
and in 2015 was the cause of 1 in 6 deaths globally (8.8 million deaths total).5
These statistics will be improved by advancing the toolsets cancer researchers use
to study the tumor microenvironment and therapeutic efficacy. Complexity within
the tumor microenvironment is derived from the increase in cell number offsetting
the homeostatic biochemical microenvironment, establishing multifactorial
gradients that are either unidentified or poorly understood. For example, many
combinatorial biochemical microenvironment parameters influence spatialtemporal

dynamics

that

control

cellular

behavior

(signaling

pathways,

transcriptional response elements, genetic instability etc.) but have yet to be
identified for the purpose of therapeutic intervention. Despite this prodigious
context, some simple relationships in the TME have been established, and these
have improved our understanding of the complex cellular interactions.6
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Conventionally, cancer is described as a disease of the genes. A large body
of work in vitro uses basic experimental model systems (for example, by harvesting
cells from a biopsy, culturing by 2D monolayer and sequencing approaches for
analysis) to investigate specific genes or mutations and design therapeutic
interventions that specifically target these genotypes.7 This silver bullet idea has
yet to be proven globally effective at treating and much less curing the multifaceted
disease.8 Approaching cancer from the framework of development based solely
on genetic information neglects the nature of the situation; cancer develops in a
dynamically evolving chemical microenvironment with combinatorial selection
pressures propagating malignant phenotypes. Darwinian principles of natural
selection (namely, phenotypic variation among individuals within a population is
heritable, and individuals with heritable traits better suited to environmental
pressures will survive) can be used to explain the evolution of heterogeneous
phenotypes, genomic instability, and the inability of targeted therapies to
comprehensively eradicate a single tumor.6,9-11
Contemplating cancer through the lens of evolution starts with identifying
environmental selection pressures (i.e. hypoxia, acidosis, depleted nutrient
availability etc.) working in combination and the adaptive cellular survival
mechanisms (i.e. change in genetic expression patterns) that ensue. It then
becomes more tractable to map these environmentally derived phenotypes to
tissue architecture as well as to genetics and identify therapeutic strategies that
could be effective over the wide range of heterogeneity observed in solid tumors.
This goal of relating changes in the chemical tumor microenvironment, in genetic
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and protein expression, and in the ability of a drug to be effective needs to
evaluated using model systems that can provide more realistic context. Finally, the
research paradigm of studying cancer primarily in 2D cell culture followed by
preclinical drug discovery investigations needs to be modernized to implement
advancements made in multidisciplinary fields. Developing new 3D cell culture
methods will enable correlative studies of environmental selection pressures with
cellular responses to produce more translatable outcomes.
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1.3

Gradients and Tumor Heterogeneity

Conventional biomedical research methods are insufficient to generate, control,
and investigate correlations within the biochemical tumor microenvironment that
develop because of altered cellular metabolism. Cellular adaptations that arise in
response further propagate heterogeneity within a tumor and directly impact
therapeutic outcomes.

Cells in a tissue field are conceptually located between nutrient sources and
waste removal systems (i.e. the vasculature) that are organized such that cells are
no farther than ~150 µm from the nearest blood vessel (Figure 1.1).12 Cells within
this local and radial diffusional transport distance of 150 µm are under strict
homeostatic mechanisms that include (1) proliferation regulation; (2) cellular
turnover by apoptosis; (3) tightly orchestrated genetic expression; (4) energetics
by aerobic metabolism; and (5) ordered extracellular matrix (ECM) and
vasculature; thus, the biochemical microenvironment is resistant to large shifts. In
contrast, tumorigenic tissues have malfunctioning homeostatic mechanisms. First
and foremost, proliferation regulation breaks down, which leads to uncontrolled
reproduction of cells, and therefore the proliferative tissue develops nutrient and
waste supply and removal demands, respectively, that exceed the capabilities of
preestablished vasculature. In addition, genetic regulatory signals are largely
ineffectual, cell turnover shifts to necrosis, the ECM and vasculature become
chaotic, metabolism shifts to glycolysis and the biochemical microenvironment is

9

Figure 1.1 Homeostatic Tissue. Idealization of a cells in a tissue field with
ordered tissue architecture and commensurate time scales for diffusional
transport and metabolic processes, leading to minimal accumulations or
depletions of biochemicals (wastes and nutrients, respectively). This
diagrammatic representation shows the vasculature blood supply on the lefthand side next to a structurally ordered and uniform tissue field with the green
overlay demonstrating the uniformity of the biochemical environment (some
gradients do arise but for the purpose of comparison to a tumorigenic tissue as
depicted in Figure 1.2, small scale gradients are not pictured here).
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Figure 1.2 Tumorigenic Tissue. In early stage tumor progression, biochemical
microenvironmental gradients arise when metabolic consumption exceeds
diffusional transport and nutrient supply. These biochemical gradients cause the
development of heterogeneous phenotypes in the tumor microenvironment. As
the figure illustrates, the cells in close proximity to the vasculature are exposed
to a nutrient rich perfusate that enables a proliferative phenotype (green
overlay). Farther away from the vasculature, the nutrient supply is depleted by
the proliferative cell metabolism upstream and thus a quiescent, nonproliferative phenotype is observed (yellow overlay). Finally, necrosis develops
at radial distances above ~150 µm away from the vasculature (red overlay)
because of extreme nutrient depletion and waste accumulation.
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subjected to large variations.13 As seen in Figure 1.2, these chemical
microenvironment variations exist as gradients and give rise to (1) a proliferative
region close to the nutrient source with abundant nutrients and high metabolic
rates; (2) quiescent cells farther away from the source and in a nutrient depleted
environment due to the metabolic activity that occurred upstream; and (3) farthest
away from the blood vessel, waste accumulation and necrosis. In short, the
dynamic biochemical environment in a tumor causes phenotypic heterogeneity to
become the prevailing qualitative characteristic.14 It is now well accepted that
heterogeneity in the TME plays a critical role in the progression of cancer, however
exisiting techniques are not suited to study this heterogeneity.
Different approaches are used to model the tumor microenvironment for
analyzing changes in genetic and protein expression in response to changes in the
biochemical microenvironment, yet many are insufficient. Existing technologies are
lacking in many critical aspects to achieve this goal (Figure 1.3). Models in vivo,
although currently the gold standard in pre-clinical research, are expensive,
complex, and have uncontrollable parameters that make establishing robust model
systems intractable.15,16 For example, mouse xenograft models of cancer (human
cell-line implantation) have short-comings including (1) unrealistically higher
metabolic and proliferative rates of cells in the system as well as the small size of
the organism and shorter lifespan in comparison to the humans it is meant to
model; (2) defined lack of parametric control for mechanistic studies because the
system is too complex to control all possible variables; and (3) the economical and
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Figure 1.3 Conventional Model Systems. Diagrammatic comparison of the
research paradigm currently accepted in biomedical investigations from 2D to
3D cell culture through pre-clinical and clinical studies.
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ethical concerns of the system.
In comparison, widespread 2D cell culture in vitro systems are too simplistic
to accurately reflect a solid tumor and while being more ethically acceptable, have
recently been proven to produce directly untranslatable results.17 2D cell culture
systems are deficient in that (1) cells are completely removed from the context of
a 3D tissue architecture and made to grow on treated polystyrene or glass
surfaces; (2) the biochemical environment is by design free of gradients, nutrient
enriched past realistic physiological concentrations, and meant to support survival
of cells in synthetic conditions; and (3) coculturing is possible although establishing
the spatial complexity and localization of cells as observed in tissue crosssectioning is impossible in conventional 2D systems. Additionally, although cellular
metabolism can be measured by instrumentation such as the Seahorse XF
Analyzer, there is still a marked lack of chemical, cellular and metabolic
heterogeneity18,19 rendering these 2D systems poor in translation.
3D culture systems have the potential to bridge the gap, so to speak,
between the 2D and preclinical in vivo model systems. The state of the art in 3D
cell culture is the multicellular tumor spheroid (MTS) model, which is defined by
aggregations of cells that grow in a spherical manner. Although this model system
has been used for nearly 40 years and encompasses key features such as the
development of biochemical gradients and the evolution of cellular phenotypes in
response, the major drawbacks are (1) the lack of uniformity in formation methods;
(2) difficult and destructive measurement of chemical and metabolic gradients; and
(3) the lack of co-culture models especially due to cells resisting formation into
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spheroids.14-16,20,21 Other alternatives, such as 3D packed bed bioreactors like the
bioartificial liver system, focus on instrumentation that avoids large-scale
gradients, instead striving to create uniform extracellular conditions for
bioproduction applications.22,23 A final important point is that the power of
multiparameter mathematical models to quantitatively predict parameters related
to tumor development and therapy response (proliferation, metabolism, viability,
drug transport) are limited by a pronounced lack of experimental data.13,14,24
Implementing systems that have the ability to measure parameters and establish
realistic initial conditions will greatly improve the use of these in silico models.
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1.4

Hypoxia in the tumor microenvironment

Avascular tumors develop oxygen and morphological gradients that apply
selective pressures favoring adaptive and resistant cells during treatment.

Cellular heterogeneity in the TME as well as resistance to therapeutic
routines is accentuated by hypoxic conditions. The term hypoxia has been used
imprecisely because of the marked increase in investigation of the condition by a
large range of disciplines. By definition, tissue hypoxia results from inadequate
supply of oxygen for homeostatic function. Biochemists extend the definition to
include oxygen limited electron transport especially in the mitochondria25 whereas
physiologists extend the definition to encompass critical thresholds that results in
the function of organs, tissues, and cells being eliminated when breached.26 The
inadequate supply of oxygen is caused by factors such as (1) low oxygen partial
pressure in arterial blood due to heart disease or high altitude; (2) anemia or the
reduced ability of blood to carry oxygen to tissues, including in the case of carbon
monoxide poisoning; (3) reduced tissue perfusion; and (4) increased oxygen
diffusion distance due to inconsistent blood flow in microvessel structure. In solid
tumors, hypoxia is established because of structural abnormalities in tumor
microvessels, disturbed microcirculation and therefore diminished oxygen diffusion
geometry.27 This is precisely the type of environmental selection pressure that
causes adaptive cellular survival mechanisms to develop, demonstrating that even
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in the simplest of cases a multidisciplinary approach is needed to fully understand
the implications of cancer and treatment efficacy.
Hypoxia is recognized to render solid tumors more resistant to radiation
therapy and recently has been thought to affect the malignant potential of a
tumor.18,28,29 These progressive phenotypes can mitigate the negative impact that
oxygen deprivation would otherwise have and enable the preservation of genomic
stability as well as the capacity to proliferate upon reoxygenation of the tissue in
question. Because of this, tumor hypoxia is typically considered a negative clinical
feature of solid tumors. Niches of hypoxia exposed cells are characteristically
problematic because ionizing radiation and chemotherapeutic drug approaches
target and selectively kill only proliferative cells in normoxic regions.30 Ionizing
radiation produces a DNA-radical that, in the presence of oxygen produces a
covalent bond that fixes the damage and leads to cell death. In the absence of
oxygen, regular DNA damage repair mechanisms mend the damage and the cell
will not die, as in the quiescent zone of a tumor.31 Conventional chemotherapeutic
approaches are designed to target cells actively undergoing mitosis and thus only
have an effect on the proliferative region of cells in a tumor, not to mention that the
drugs themselves are also subject to high metabolic uptake as well as diffusional
transport limitations. This creates a scenario where the nutrient depletion that once
prevailed in the quiescent zone is reversed, metabolism becomes aerobic, cells
switch to proliferation, and the daughter generation has a high likelihood of being
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Figure 1.4 Hypoxic Tissue. Tissue sectioning and results from polarographic
electrode measurements adapted from Gray et al. and Terris et al.32,33 The
tissue section shows the context in which an avascular tumor mass expands
and the resulting phenotypic variation: surrounding stromal regions, proliferative
band of tumor cells, quiescent region which gives rise to a radioresistant
population of cells, and centralized necrosis. By comparing the histograms from
normal vs tumor tissues, it becomes apparent that the oxygen tensions are
remarkably distinct, and this supports the original thinking posed by Gray et al.
(Images modified from source 32,33)
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phenotypically adapted to survive in increasingly aggressive environmental
conditions, driving malignancy.29
This heterogeneous pathology was first observed by Thomlinson and
Gray32 in a series of pioneering studies that included tissue sectioning and staining
by hematoxylin in the 1950’s (Figure 1.4). Tissue cross-sectioning shows that
vascular stroma is in contact with either normal or neoplastic epithelium, but
capillaries do not penetrate the tissue and so the delivery of nutrients is strictly
through diffusion of the tissue. In larger tumors the distance between blood vessels
and necrosis is a constant distance (>150 µm) and predicted to be the O2 diffusion
distance (given ppO2 and oxygen consumption of cells). Gray et al predicted that
viable hypoxic and radioresistant cells would be adjacent to the necrotic regions of
tumors. These qualitative results were quantitatively verified with polarographic
oxygen electrode experiments from 37 patients.33 A mounted electrode the size of
a needle was automatically advanced through either a normal or tumorigenic tissue
and recordings were taken within 1.4s to avoid changes in oxygen tension resulting
from pressure artifacts and tissue damage by the electrode itself. Although the
discrete location of the electrode was unknown, a resulting histogram of oxygen
tensions from multiple points within the tissue is still produced. In oxygenated
tissue, the oxygen tensions follow a Gaussian distribution with no values less than
10 mmHg. It is worth noting that the distribution of the oxygenated tissue spans a
wide range due to transient oxygen supply from the vasculature as well as changes
in metabolic consumption rates as a function of position within the tissue, which as
mentioned is not recorded with the electrode technique. In the tumor tissue
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measurements, the median of roughly half the tumors have a value less than 10
mmHg. This value correlates to the point at which radiation resistance starts to
develop, with full resistance at values less than 0.5 mmHg. In essence, the
development of hypoxic conditions directly leads to clonal selection of cells that
have accumulated adaptive advantages to survive harsh environmental
conditions.
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1.5

Oxygen and the Hypoxia Inducible Factor Pathway

HIF-1α is an oxygen-responsive transcription factor that enables cellular
adaptation to hypoxic conditions by modulating expression of proteins.

At the cellular level, hypoxia-inducible transcription factor 1 (HIF-1) is a
classical pathway that enables cells to adapt to harsh environmental conditions by
directly upregulating proteins that enhance the ability to survive in poorly
oxygenated states.28 Molecularly speaking, HIF-1 is a well understood,
dichotomous pathway in terms of oxygen rich vs depleted levels in the extracellular
biochemical microenvironment.34 HIF-1 is a heterodimer that consists of: (1) HIF1α, the hypoxia response factor and (2) the constitutively expressed aryl
hydrocarbon receptor nuclear translocator (ARNT, also known as HIF-1β). In the
presence of oxygen, prolyl hydroxylase domain proteins (PHD) covalently modify
HIF-1α by hydroxylation of proline residues 402 and 564.35 This form of HIF-1α
interacts with the tumor suppressor Von Hippel-Lindau (VHL) protein (with binding
further stabilized by acetylation of lysine residue 532 by acetyltransferase ARD1),
causing HIF-1α to become ubiquitylated by an E3 ubiquitin-protein ligase.
Ubiquitylation targets HIF-1α to the 26S proteasome where it is degraded (Top of
Figure 1.5).36,37 In the absence of oxygen, the rate of hydroxylation and acetylation
on HIF-1α decreases, VHL cannot bind, and the degradation rate of HIF-1α
similarly slows. The coactivators, p300 and CBP bind to HIF-1α in the absence of
hydroxylation and the complex translocates to the nucleus where it subsequently
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interacts with ARNT/HIF-1β. Finally, DNA polymerase II joins the complex bound
to hypoxia-response elements (HREs) on DNA, activating the transcription of
target genes (Bottom of Figure 1.5).38,39 The sheer number of downstream genes
that are transcriptionally activated by HIF-1 is remarkable and covers cellular
regulation schemes including but not limited to cell proliferation, cell survival,
apoptosis, cytoskeletal structure, cell adhesion, erythropoiesis, angiogenesis,
vascular tone, transcriptional regulation, drug resistance, tumor acidosis, and
metabolism (nucleotide, iron, glucose, ECM, energy, amino acid). The latter two,
tumor acidosis and cancer metabolism, have recently been acknowledged to not
only add complexity to the idea of survival of the fittest population of cells in the
TME but can work in combination with hypoxia to enhance pro tumor effects.
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Figure 1.5 Regulation of HIF-1α. Representation of HIF-1α and how it is
modulated in two states of oxygen tension. The top shows the chemical
modification within protein domains that are responsible for the degradation of
HIF-1α in the presence of oxygen; the bottom shows nuclear translocation and
genetic upregulation of survival proteins in the absence of oxygen.
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1.6

pH and the Hypoxia Inducible Factor Pathway

Tumor acidosis is a key regulator of tumor progression and metabolic
reprogramming that hypothetically stabilizes cytoplasmic HIF-1α.

The current understanding of pH homeostasis and metabolism is based on
studies using differentiated, nonproliferating cells which provides insight to
baseline energetics. For example, in the presence of oxygen, cells metabolize
glucose to carbon dioxide by redox reactions in the tricarboxylic acid cycle. This
produces NADH which is the currency for oxidative phosphorylation in the
mitochondrial membrane to fabricate a maximized amount of ATP, roughly 36
molecules with minimal lactic acid production. In contrast, large amounts of lactic
acid are produced only in anaerobic, i.e. hypoxic, conditions when oxygen is
unavailable for the oxidation of glycolytic pyruvate where it is instead shunted into
lactic acid production and minimal ATP production (about 4 molecules) (Figure 1.6,
left hand side).40 Conventionally, tumor acidosis arises from proliferating cells
metabolically undergoing glycolysis regardless of oxygen conditions and as a
direct consequence the accumulation of extracellular lactic acid, a concept known
as the Warburg effect (Figure 1.6, right hand side). Although this might seem
energetically counterintuitive as it does not yield the maximal amount of ATP, it is
important to point out that during active mitosis the energy demand of the cell is
not only for ATP production but to also double the biomass within the cell for
division.41 With this in mind, for a cell to divide, the energetic fate of a glucose
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molecule is not only for carbon catabolism for ATP production but to also supply
biomass components for nucleotides, amino acids, and lipids.42 Nevertheless, this
metabolic reprogramming changes both the intracellular and extracellular pH
balance, potentially influencing the malignancy of a tumor. Although hypoxia is by
far more studied, tumor acidosis has recently been identified as a major hallmark
of tumors and a key regulator in tumor progression.43
There has been speculation as to the order of operations in cancer
pathophysiology as it relates to hypoxia, acidosis and metabolism. That being said,
it is not clear if specific relationships between hypoxia, tumor acidosis, and
metabolic reprogramming are mutually exclusive or mutually beneficial to the
survival of cancer cells. Acidification of the extracellular environment results from
the accumulation of H+ ions as well as lactate likely because of a shift in the
intracellular/cytosolic compartments of tumor cells from neutral to acidified.44,45,46
In the event that intracellular pH is acidic, the efficiency of enzymes changes as
some amino acid residues within proteins may become ionized leading to
functional alterations, metabolic shifts, and potential triggering of cell death.47 This
effect is a selection pressure that potentially gives rise to phenotypic adaptions
which contribute to maintenance of pH in an optimal range.
More globally speaking, chemical and metabolic gradients are established
because of uncontrolled cellular proliferation in a tumor mass and therefore
extended diffusional mass transfer distances from vasculature, leading to largescale regions of combined hypoxia and acidosis.48 Cells with more aggressive
phenotypes, as mediated by cytoplasmic stabilization of HIF-1α in hypoxia, are
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thought to be resistant to both radiation and chemotherapies, thus driving
malignant progression.49 However, chemoresistance is not characteristic of all
hypoxia-exposed cells and the role that extracellular acidosis plays in combination
with normoxia remains unclear. HIF-1α activity is implicated in therapy resistance
due to pro-tumor effects, although some changes observed in hypoxic cells can
result in increased drug sensitivity. Interventions that aim to target cancer by pH
disruption require an improved understanding of how altered microenvironmental
conditions influence adaptive phenotypes.50
In 2D cell culture models, cancer cells have been shown to survive stressed
microenvironments by selecting phenotypes that enhance survival including
suppressing apoptosis, initiating angiogenesis, and enabling a switch in energy
metabolism.45 However, it is unclear how the microregional distribution of HIF-1α
is modulated by coupled or uncoupled gradients in hypoxia and acidosis because
these 2D cell culture models lack the spatial complexity of a 3D model system.51
HIF-1α controls the hypoxia induced, adaptive metabolic switch from oxidative
phosphorylation to glycolysis, which results in the accumulation of lactic acid. It
was once thought that acidosis was only toxic to cells, but it is now clinically
recognized that mild acidosis (pH 6.5 and above) is protective and possibly acts
as an input to other metabolic pathways.52 Additionally, lactic acid can indirectly
stabilize HIF-1α and is thought to perpetuate the activation of HIF-1α independent
of hypoxia, but the mechanism has yet to be determined. An increase in the activity
of HIF-1α and subsequent metabolic programs alters the generation of pH and
oxygen gradients by cancer cells and directly influences survival.53 Therefore,
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more aggressive cancer cell phenotypes evolve in order to survive stressed
microenvironments. We hypothesize that there are combined low pH and high
oxygen conditions that enhance HIF-1α mediated metabolic adaptations, thereby
promoting cell survival. This hypothesis is an exemplary case that demonstrates
the need for improved technology in order to mechanistically investigate the
complex interacting parameters of acidic, hypoxic, and nutrient deprived
environments on tumor cell proliferation, survival and metabolism.

27

Figure 1.6 Tumor Metabolism. Diagrammatic representation of the metabolic
and pH conditions in normal (left) and tumorigenic (right) tissues. Cells under
homeostatic regulatory mechanisms in the presence of oxygen use oxidative
phosphorylation as the main energetic pathway in order to maximize ATP
production. In the absence of oxygen, cells with intact regulatory conditions
undergo the conversion of pyruvate to lactate which in turn acidifies the
extracellular environment. Under dysregulated energy control mechanisms cells
have been demonstrated to switch metabolic programming regardless of the
presence of oxygen in order to meet the energy demands for biomass
production, as in highly proliferative cells in a tumor.
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1.7 Conclusion and Outline of Subsequent Chapters
In summary, this dissertation establishes three distinct droplet-based 3D
cell culture techniques that each contributes to the field of droplet generation and
develops these technologies for the biological applications of cell encapsulation,
3D proliferation assays, culture of biomaterial supported spheroids, and growth of
encapsulated cells in altered biochemical microenvironments. In addition to a
review of the cancer research model paradigm and a description of the deficiencies
in existing technologies, a classic biomedical research hypothesis is posed to
demonstrate the need for improved 3D culture systems when investigating
combinatorial parameters.
The remainder of this hybrid dissertation will progress as follows. Because
this work is highly multi-disciplinary and cooperative, Chapter 2 summarizes the
specific contributions from collaborators including Professors, fellow graduate
students, and undergraduate mentees to make sure due credit is received.
Chapter 3 describes the development of high-throughput droplet generation in air
with acoustic modulation and introduces the biomaterial cell encapsulation
solutions that are common to all remaining chapters in the work. Chapter 4 details
the controlled generation of monodispersed cell-encapsulating droplets in waterin-water emulsions using a lower throughput microfluidics platform and speaker
derived acoustics. Chapter 5 focuses on centrifugal droplet generation and
highlights this as the preferred platform to produce monodispersed and spherical
droplets with a medium to high throughput for all relevant biological applications.
Chapter 6, although sometimes in the context of work in progress, establishes the
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development of proliferation tracking assays using both qualitative and quantitative
growth curve measurements in 2D vs 3D mono- and co-cultures, the instant
formation and culture of biomaterial supported spheroids, and the design
considerations for implementation of 3D culture systems that alter and control the
biochemical microenvironment for hypoxia and acidosis investigations. Chapter 7
provides high-level conclusions and discussion for the entirety of the dissertation.
Each chapter has its own List of References included as the last section.
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Content and Contributions

41

2.1

Content in Chapters 3-7 and Contributions Made

A high-level overview of each subsequent chapter is provided along with a
description of the contributions to the experimental designs, results and data
analysis as well as conclusions.

Chapter 3 presents the design, construction, and optimization of a droplet
generating instrumentation platform that enables high-throughput droplet
formation in air using acoustic actuation of a flow stream. The design and
implementation of different device designs, fluorescence and freeze frame imaging
in real-time, optimized device parameters, and two different droplet collection
mechanisms is reported. The use of biocompatible chemistries is investigated and
demonstrates a first attempt at the use of aqueous two-phase separation in highthroughput droplet generation by acoustic modulation in air.
The majority of the work was carried out by Jacqueline De Lora, working
with the advisement of Professors James Freyer and Andrew Shreve. Her
contributions included leading the effort on device design and construction,
developing the chemistry and cell culture methods, designing and implementing
the pneumatic flow system and optical imaging system, implementing electronic
and acoustic approaches to assist droplet generation, characterizing the device
performance over a range of flow rates and frequencies and implementing and
assessing droplet capture methods. For portions of this work, she was assisted by
undergraduate students Jason Velasquez and Emily Innis, both of whom she
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mentored

during

their

undergraduate

research

experience.

She

also

acknowledges the assistance of graduate students Daniel Kalb and Travis Woods
for help in the acoustic and electronic components of the work.
Chapter 4 presents a highly collaborative work that demonstrates the use
of an integrated microfluidics/acoustics approach to encapsulate cells in an
aqueous two-phase system. The acoustic break-up of an aqueous two-phase
system into droplets in the microfluidics device is characterized using enriched
polymer solutions that are designed for 3D cell culture applications, flow
rate/frequency optimization matrices for monodisperse droplet generation,
rheology and index of refraction measurements to characterize physical properties
of the polymer solutions, and the influence of acoustic modulation on droplet
diameter. Cell concentrations are investigated and optimized for producing cell
encapsulating droplets that are demonstrated to proliferate in optimized
suspension culture for 9 days. The use of an Annexin V/PI flow cytometric assay
to assess the biocompatibility of the polymer solutions used for cell encapsulation
is also reported. This droplet-based cell encapsulation approach validates the use
of aqueous two-phase systems in microfluidics and for 3D cell culture applications
in cancer research.
Jacqueline De Lora led the portions of this effort that involved development
and adaptation of polymer solutions for cell culture applications, development and
implementation of the protocols for cell encapsulation and suspension culture, all
cell assays such as cell counting and flow cytometry measurements, working
under the advisement of faculty members Andrew Shreve and Nick Carroll. She
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also worked closely with graduate student Frank Fencl, and assisted his efforts to
develop and implement the microfluidic device design, and worked closely with
both Frank Fencl and undergraduate student Aidira Dora Yajaira Macias Gonzales,
who led the work characterizing the aqueous two-phase separation properties. In
addition, New Mexico State University graduate student Alireza Bandegi and
Professor Reza Foudazi are acknowledged for their work in measuring rheology
data of the polymer/cell solutions.
Chapter 5 describes the use of centrifugal force to synthesize cell
encapsulating droplets with a moderate throughput and optimized control over
droplet size as well as cell concentration in the droplets. This chapter demonstrates
improvement of centrifuge tube assemblies with new hybrid nozzles, optimization
of droplet generating regimes and control over droplet size in device operation, as
well as applications that include the first instance of generation of super small
droplets, and the encapsulation and measurement of low and high cell occupancy
droplets. This chapter sets the stage for using this preferred method for all cancer
biology applications discussed and in progress in Chapter 6.
Jacqueline De Lora carried out the majority of the work in Chapter 5 with
the advisement of Professors James Freyer and Andrew Shreve. Her contributions
include leading the design and construction of centrifuge tube assemblies with
hybrid nozzles for both cell encapsulating droplet generation as well as cell-sized
droplet generation. For portions of this work, she was assisted by undergraduate
students Jason Velasquez (optimization and image analysis) and Cody Moezzi
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(cell-sized droplet generation), both of whom she mentored during their
undergraduate research experiences.
Chapter 6 begins the exploration of using cell encapsulated droplets,
primarily generated using technology developed in Chapter 5, to establish more
realistic 3D culture environments with standardized biological assays. The growth
rate of two relevant cancer cell lines in 2D mono- and co-cultures are measured
using cell counting growth curves and fluorescence membrane dye dilution flow
cytometric assays. Then these assays are adapted to 3D culture using cell
encapsulated droplets generated by centrifugal synthesis in proof-of-principle
experiments, demonstrating feasibility. High cell occupancy droplets are generated
and grown in suspension culture for 7 days to demonstrate the use of the platform
as an improved approach for the generation of scaffold supported instant
multicellular tumor spheroids. Finally, an experimental system for the 3D culture of
low cell occupancy droplets in altered and combinatorial chemical environments is
designed and constructed towards the end of establishing an improved method to
investigate the biomedical question posed in Chapter 1.
Jacqueline De Lora is responsible the experimental designs and results
obtained in Chapter 6 under the advisement of Professors James Freyer and
Andrew Shreve. She performed the growth curves and fluorescence dilution
curves in 2D and 3D, she designed and implemented the instant multicellular
spheroid experiments, and she constructed the system for altered environment
experimentation. Jacqueline is continuing to work towards taking the experiments
for 3D growth curve and fluorescence dilution as well as altered environments past
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the level of “proof-of-principle” for inclusion in publications in preparation. For
portions of this work, she was assisted by undergraduate students Jason
Velasquez and Emily Innis, as mentioned before.
Chapter 7 provides a discussion of the work accomplished in the
dissertation and the future directions of the work.
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Chapter 3

High-throughput Acoustic Droplet Generation in Air
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3.1

Controlled Mass-Production of Droplets

Development of new high-throughput droplet generating instrumentation and
devices that enables use of highly viscous biomaterial polymers, high speed
droplet formation by acoustic modulation, and two potential approaches to
droplet solidification mechanisms is presented.

2D cancer model systems are the standard laboratory approach for the
investigation of mechanisms underlying the biology of cancer. More recently,
motivated by the disparate results when comparing 2D cell culture to in vivo
experiments, researchers have realized the need to use more complex and
physiologically realistic 3D model systems that can closely mimic the tumor
microenvironment (TME).1,2 With the need to use more biomimetic 3D cell culture
models comes the realization that new instrumentation is required to facilitate this
shift in standard lab practices. In order to achieve more accurate representations
of cancer tissues and greatly accelerate progress, especially as applied to highthroughput drug screening for personalized medicine3, many investigators have
used existing model systems such as (1) multicellular tumors spheroids grown in
suspension by conventional formation methods4; (2) microfluidic systems to
generate and culture 3D cell containing scaffolds5; (3) gel embedding into
extracellular matrix analogue materials6; or (4) cell bioprinting to make layer by
layer 3D tissue constructs7. However, many of these technical approaches face
technical challenges that make them unrealistic in terms of fully replacing 2D cell
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culture as the standard lab practice. These challenges include the overall
throughput of the system, which tends to be low in microfluidic systems; difficulty
in flowing highly viscous biomaterial solutions through devices; generating small
constructs of uniform composition and size; as well as the cost and time it takes to
implement these new platforms into lab practices. Taking these challenges into
consideration, it is clear that an approach combining knowledge from many
technical fields is best suited for accomplishing the design, construction, and use
of a system with the ability to generate large populations of uniform 3D cell
scaffolds that can easily interface with existing high-throughput technologies.
With these factors in mind, the design of the in-air acoustic droplet generator
is inspired by the field of flow cytometry (droplet-based cell sorting) to produce a
robust droplet generating instrumentation platform that operates at high frequency
(up to 25,000 droplets/second), can handle highly viscous biomaterial solutions
through the integration of amplification electronics, has a narrow and small size
distribution for droplets generated in the air (down to 100 µm diameter drops), and
uses devices and optical components constructed from inexpensive materials. The
high-level goal of this new instrumentation platform (described in section 3.3) is to
produce 100 µm diameter calcium alginate droplets with encapsulated cells for 3D
cell mono- and co-culture applications. A droplet diameter of 100 µm is desirable
to therefore prevent the generation of intra-droplet gradients (generally accepted
to develop past ~150 µm radial distances8 depending on cell occupation, the
availability of nutrients, and cellular consumption rates).
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Interestingly, one of the challenges of this method arises from its highthroughput nature. The flow conditions needed for stable droplet generation in the
desired size range correspond to high linear flow velocities. In turn, this set of
conditions leads to difficulties in capturing and cross-linking individual spherical
droplets, and many design iterations have been explored in an attempt to generate
and solidify stable droplets. There is still further optimization to be done for the cell
encapsulation aspect of this work, but the results presented provide the first
instance of high speed droplet generation using an instrumentation platform that
would be as easy to implement into a laboratory as a flow cytometer.
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3.2

Device designs

Glass capillary devices and piezoelectric transducers are interfaced to produce
either dual or single channel droplet generating devices.

Two device designs have been investigated for use in the high-throughput
acoustic droplet generating instrumentation platform. The first devices are
designed with a nesting core/annular fluidic profile to use the principle of
hydrodynamic focusing to help control the size of the biomaterial droplet produced
and possibly enable droplet crosslinking in air. The second devices are designed
with a more simplified, single stream profile to enable the direct acoustic
modulation of droplet formation in air. Dual channel devices are constructed using
a simple tee-junction tubing connector (Cole Parmer 1/16” Nylon Tee Fitting) and
slip-fit tubing (Cole Parmer Rubber tubing 2.4 mm O.D. 0.70 mm I.D.) serving as
the anchoring point for the nesting of two capillaries. The capillaries are two
different dimensions matched for housing one within the other (Borosilicate Glass
from World Precisions Instruments, Outer Capillary 1.5 mm O.D. 1.12 mm I.D. and
Inner Capillary 1.0 mm O.D. 0.58 mm I.D. both 155 mm long). They are pulled to
a taper using a P-97 Flaming/Brown Micropipette Puller (Sutter Instrument Co.)
and soldered or cut to a defined nozzle diameter using a MF-830 Microforge
(Narishige Group), typically 100 µm inner nozzle and 200 µm outer nozzle
diameter. To assemble the nesting dual channel device, the slip-fit flexible tubing
junctions are placed onto the two long axis ports of the tee-junction connector.
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Then the 11.2 cm long inner capillary is threaded through the long axis of the tee
connector/slip-fitted tubing and secured closer to the blunt end capillary/tee
connector arm, making sure to position it so that the inner capillary will not push
through the outer nozzle once it is in place. The 7.2 cm short outer capillary is
threaded over the inner capillary with the 100 µm nozzle end and carefully pushed
up into the slip-fit piece of tubing to attach it to the tee-junction as well. To connect
the piezoelectric element in the dual channel device, a rectangular piezoelectric
transducer (5 cm, Boston Piezo Optics) is super glued to a 5 cm long, 3.2 mm O.D.
1.7 mm I.D. stainless-steel tube (Valco). This method is preferable in comparison
to direct attachment of the rectangular piezoelectric transducer to one side of the
glass capillaries, as the unevenly distributed weight of the crystalline material in
the latter case causes misalignment of the nesting nozzles. Finally, a small amount
of ultrasound gel (LiquaSonic Ultrasound Gel) is applied to the length of the outer
capillary of the dual channel device and the entire device is carefully threaded into
the stainless-steel tubing/piezoelectric assembly, establishing an acoustic energy
transducing interface between the glass capillaries and the piezoelectric
transducer (Figure 3.1). Single channel devices are simple in their design and
implementation. A capillary nozzle is fabricated as described above using the
pulling and soldering method to any desired nozzle diameter (usually between 50100 µm diameter). The piezoelectric transducer is super glued directly onto the
side of the glass capillary and fluidic lines are attached by slip fitting rubber tubing
over the blunt end of the capillary. The device is mounted by clamping directly onto
the glass capillary above the piezoelectric transducer.
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Figure 3.1 Dual Channel Device. Diagram depicting the core-annular flow
profile of a dual channel device with fluorescence light path in the instrument as
well as the actual two channel device assembled with a tee junction and the
piezoelectric transducer coupled to the stainless-steel mounting tube. On the
right is an image of an operating dual channel device at the nozzle, with dye
incorporated into the core flow stream. This image shows the nesting capillaries
as well as hydrodynamically focused core/sheath fluid flow.
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3.3

Instrumentation operation

Fluidic, optical, and electronic design of the droplet generating instrumentation
enables robust pressure driven fluid flow and device optimization through realtime imaging during operation.

The droplet generating instrument is primarily built using materials obtained
from ThorLabs optomechanic kits, including components such as an aluminum
breadboard as the base, posts and post holders, optical mounts, lenses and filters,
translation stages, and a self-centering mount to vertically secure the device in a
suspended position (Figure 3.2). Specifically, post holders are arranged so that all
optical components are held above the breadboard in an orientation such that the
optical paths orthogonally intersect the vertical, downward flow stream of the
device. The device and the camera mount can both be translated in x, y and z
directions. For imaging droplet generation in real-time, the device is back-lit with a
broad spectrum white LED strip (Super Bright LEDs) and homemade diffuser
(simply a microscope slide with a strip of cloudy scotch tape mounted in front of
the LED). The LED is synced to strobe at the same piezoelectric modulation
frequency that governs the droplet formation rate by using a Tektronix AFG 3102
dual channel function generator (Figure 3.2 C and D). This technique produces a
freeze frame effect to image the high-frequency droplet generation. A 25.4 mm
diameter lens with a 25.4 mm focal length (Bi-Convex Uncoated Lens Model
KBX046, Newport) is used to collect light from the region of the stream and image
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relay to create an image on a ThorLabs Compact USB 2.0 CMOS Camera (Figure
3.2 B). The capability to image fluorescence in addition to the backlit image is
integrated into the optics by assembling a 25 mm diameter collimating aspheric
lens with a 20.1 mm focal length (Asphere Lens Model ACL2520U-A, ThorLabs)
and a 25.4 mm lens with a 38 mm focal length (Plano-Convex Lens Model KPX079,
Newport) in sequence orthogonally to the white LED light path (Figure 3.1).
Fluorescein is used as the fluorophore in dual channel device operations and as
such, the excitation source used is a point source blue LED, which emanates
diffuse light. This diffuse light is collected into a lens tube assembly containing the
aspheric lens to broadly focus the light that then travels into the 25.4 mm, f = 38
mm focusing lens with a 450/40 filter (here, 450/40 refers to a bandpass spectral
filter of 40 nm full-width-at-half-maximum transmission, centered on 450 nm
wavelength; similar notation is used throughout this section) to ultimately focus the
blue light to a roughly 1 mm spot size, which intersects the flow stream. For
fluorescence imaging, a 530/15 filter is placed in front of the CMOS camera.
Additionally, an amplifier (Acoustic Cytometry System, Los Alamos NM, Model H7
PIN 103) with an external power supply (BK Precision DC Power Supply Model
1711) is integrated into the electronic set up to increase the strength of the acoustic
driving field, and an oscilloscope (Tektronix TDS 2004B) is used to measure the
resulting voltage and waveform as drawn in Figure 3.2 C.
Fluid flow into the device is produced using a pneumatics system rather
than syringe pumps (Figure 3.2 A). This is an important distinction as it was
discovered that the highly viscous nature of the biomaterial solutions used in this
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work overcomes the power of the syringe pump driver arm, creating a back
pressure and causing the fluid to be injected with oscillations rather than uniformly.
Therefore, two gas cylinders of 5% CO2 BAL AIR are connected to the in-ports of
two stainless steel pressure tanks (reclaimed from a Becton Dickinson FACS
instrument) using Tygon tubing and hose-barbed brass tubing adapters. The steel
pressure tanks contain the fluids for supply to the inner and outer capillaries and
are equipped with precise low pressure digital pressure gauges (Grainger
Industrial Supplies). Details of the solution content are discussed in section 3.4,
and the fluids inside each pressure tank are contained in glass beakers with a
Silastic tubing line (Cole Parmer) submerged to the bottom of the beaker. This
tubing line extends through the out-port of the pressure chamber and connects by
slip fit to the blunt end of the inner capillary for the core flow injection or to the
orthogonal hose barb on the tee connector of the device for the sheath injection.
In the case of single channel device operations, only one pneumatic line is needed
and the Silastic fluid flow tubing is slip fit directly onto the glass capillary (Figure
3.2 A).
Finally, this work investigates the necessary physical properties and
feasibility of the collection and solidification of high-speed droplets. Two different
droplet collection methods have been explored. Regardless of the mechanical
droplet collection method used, it is integrated into the instrument and positioned
underneath the device on the breadboard. The first collection method uses a stir
plate (VWR Magnetic Stirrer Model C2) and beaker containing the droplet
solidification solution with a stir bar to mix the solution as the droplets are collected.
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The second collection method uses an Arrow 850 driver (Arrow Engineering Co.
Inc.) connected to a bearing attached to a small aluminum breadboard with an Oring. The bearing is used to rotate a cardboard platform that securely holds flasks
of different diameters and heights containing the droplet solidification solution. This
rigid body rotating design creates a non-turbulent mixing environment.
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Figure 3.2 Instrumentation Schematic. Droplet generating device schematic
depicting the integration of (A) pneumatics, (B) optics, and (C) electronics to
produce an instrument that has fine control over the fluid dynamics in the device
(D) with the capability to image in both brightfield and fluorescence modes. For
detailed description of the construction and operation of the instrument,
acoustics and devices (see Sections 3.2 and 3.3).
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3.4

Biocompatible Droplet Generation

The basic biomaterial approach using alginate is characterized and investigated
in both dual and single channel droplet generation with collection by stir plate
mixing/collection mechanism.

Alginate is a linear block copolymer containing mixed blocks of (1,4)-linked
β-D-mannuronate (M) and α-L-guluronate (G) residues that is derived from brown
seaweed and processed into powders of differing compositions. It is now very well
understood how different block lengths, combinations of G/M, and the source of
the alginate itself influences its physical properties such as molecular weight and
viscosity. The G-blocks crosslink in the presence of divalent cations to form
hydrogels with a porous structure that may be tuned depending on the composition
of G:M (Figure 3.3).9 In general, the alginate (ALG) powder is measured in weight
percent by volume and dissolved in a physiological buffer of 25 mM HEPES and
150 mM NaCl (Sigma-Aldrich) overnight with vigorous stirring. Because of the
highly viscous nature of all biomaterial solutions, a special pH electrode that can
more accurately measure viscous and colloidal solutions (Orion Ross SureFlow pH Electrode with Sure-Flow Junction, Thermo-Fisher) is used to adjust the
pH to 7.4. Sterilization of the solutions is also required for cell culturing. Sterilization
by autoclave is not an option as the high heat changes the polymer structure and
the ability to crosslink. The viscosity of ALG solutions higher than 1% w/v make it
impossible to filter through the standard 0.2 µm pore size for sterilization but it was
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Figure 3.3 Alginate Crosslinking. Molecular structure of alginate (left top) and
representation of the interaction between sterically available carboxylic acid
groups of G-blocks solidifying the gel by the egg box model (left bottom) as well
as a depiction of the intermolecular forces that cause crosslinking by the
arrangement of carboxylic acid groups of the G-blocks around divalent cations,
in this case calcium (right).9,10
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found that sterile filtering through a 0.45 µm bottle top filter assembly (Nalgene,
VWR) is possible under high vacuum.
Dual channel device operations were first completed using 2% ALG in the
inner core flow with the sheath solution consisting of the physiological buffer
without ALG. The solidification buffer was a separate 1M CaCl2 solution stirred in
a beaker below the nozzles. The flow rates in the device are measured by
pressurizing the core chamber to 5 PSI (for this example) and keeping it consistent
through the characterization. The sheath flow rate is measured for a range of
pressures from 5 to 14 PSI in the corresponding sheath fluid chamber. The
individual flow rates for the sheath and core are measured in triplicate by first
weighing the volume of each fluid before placing into the pressure chamber. The
fluid chambers are pressurized to the desired PSI and the combined fluids are run
through the device for a precise amount of time. The fluid flow is stopped and the
weight of the fluids in the core and sheath chamber are re-weighed. The density
of the core and sheath fluids are also necessary to determine the flow rate. The
densities are measured in triplicate by zeroing an analytical balance with a weigh
boat and a 1000 µm pipette tip. Then 1 mL of the solution in question in pipetted
up into the tip and the entire 1 mL of solution and tip is placed on to the weigh boat
on the analytical balance and the weight in grams is recorded. These values are
then used to determine the flow rate in mL/min (Figure 3.4 and Table 3.1).
Additionally, the hydrodynamic focusing of the flow rate pairs is measured in
triplicate by taking three fluorescent images of the nozzle interface within the
device and using ImageJ to threshold the images and measure the thinning

61

diameter of the core flow stream. The focusing is calculated assuming the sheath
O.D. is consistent with the 200 µm diameter outer nozzle (Table 3.2 and Figure
3.5).
The droplet modulation frequency by the piezoelectric transducing crystal
has been optimized over a range of frequency/flow rate combinations. For these
experiments, the core fluid flow is held constant while the sheath flow is
incrementally increased and the modulation frequency is scanned across a range
to find stable droplet formation. It was observed that an increase in sheath flow
rate typically requires a higher modulation frequency and will shift the droplet
formation downstream. In the majority of frequency/flow rate combinations
attempted, amplification of the signal up to 50 Vp-p is required to modulate the
droplet formation (Figure 3.6). Finally, the solidification of core-annular droplets
both in a collection bath and during transit in the air has been attempted. In most
cases, collecting core-annular droplets directly into a 100 mM CaCl2 solidification
bath did not produce solidified, spherical particles. Crosslinking of the droplets
during transit in air was investigated by adding up to 38 mM of CaCl2 to the sheath
solution in an attempt to create a crosslinked shell around the droplet and aid in
particle stabilization. However, this experiment was not successful because of the
spatial arrangement of the fluid flow within the nozzle. There is a short distance
before exiting the nozzle where the alginate core and calcium sheath begin to gel
and cause clogging. In the dual channel droplet generation, successful
solidification of spherical alginate particles formed within sheathed droplets has yet
to be demonstrated.
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Figure 3.4 Dual Channel Flow Rates. Measured volumetric flow rates by
increasing the sheath pressure and holding the core pressure constant. The
negative slope observed in the core volumetric flow rate is consistent with the
increased sheath volume being displaced over time and at higher pressures,
indicating that hydrodynamic focusing in the device is achieved. Error bars are
smaller than the points on the plot and standard deviations are reported Table
3.1

Table 3.1 Table of flow rates. Flow rates determined by measuring the total
volumetric displacement of solutions over a range of pressures.
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Figure 3.5 Hydrodynamic Focusing. Plot demonstrating that as the sheath
flow rate is increased in the pressure-drive flow system, the diameter of the core
stream decreases. This principle of hydrodynamic focusing is well described in
the field of flow cytometry and can be used here to further influence the diameter
of the droplets. Each measurement was recorded in triplicate and the standard
deviation as well as CV are reported in Table 3.2.

Table 3.2 Hydrodynamic Focusing Table. Measured sheath flow rates and
the corresponding core diameter measured by ImageJ analysis.
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Figure 3.6 Dual Channel Droplets in Air. Optimization of the dual channel
device with a constant core flow rate and increasing sheath flow rates. The
images of droplets transiting in the air are captured at the same location
downstream of the nozzle. The piezoelectric modulation frequency increases
with increasing sheath flow rate and at a certain threshold the droplet break off
point is driven farther upstream/towards the nozzle.
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A simpler method is used to measure the flow rate in single channel devices
(100 µm nozzle diameter). The flow rate of the alginate fluid is measured by
weighing the amount of solution displaced over a given time. The measurements
were done in triplicate and compared against buffer as a reference (Figure 3.7 A).
The density of each solution is also measured in triplicate by zeroing an analytical
balance with a weigh boat and a 1000 µm pipette tip. Then 1 mL of the alginate is
pipetted up into the tip and the entire 1 mL of solution and tip is placed on to the
weigh boat on the analytical balance and the weight in grams/mL is recorded. At
different flow rates it was observed that droplet formation can be tuned over a wide
range of frequencies (1-40 kHz), but there is an optimal frequency that best
matched the flow rate in terms of sphericity and spacing of the droplets in air
(Figure 3.7 B) which is important in timing the collection of individual droplets. This
result can also be expressed by comparing the optimal frequency to the pressure
(Figure 3.7 C). Once the flow rate and frequency parameters have been set, the
distance out of the nozzle to the droplet break off point, the shape of the droplet
break off and the uniformity of the droplets after the breakoff point are used as
measures of optimized parameter combinations. Generally, these interacting
parameters are considered optimized once the droplet breakoff point has been
minimized to less than 2.5 cm from the nozzle with spherical particle shape (Figure
3.7 D). This optimization scheme is visually demonstrated by comparing the
droplets in air over the pressure/frequency combinations by imaging (Figure 3.8).
In both the dual channel and the single channel device design platforms,
using simplified alginate solutions and a collection method that captures the

66

droplets in a stirred solidification bath has never produced particles that are
consistent in shape with droplets observed in the air. Although the method here is
an important demonstration of high-throughput droplet generation using highly
viscous biomaterial solutions, parameters such as the crosslinked droplet
diameter, monodispersity, and reproducibility are critical factors when considering
the biological application of 3D cell culture for cancer research. We therefore
undertook another iteration of device design and implementation to attempt to
improve upon performance in capturing uniform and spherical alginate hydrogels
for 3D cell culture.
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Figure 3.7 Single Channel Optimization. Characterization of a 100 µm single
channel device over a range of (A) pressure driven measured flow rates, (B)
optimal frequencies and flow rate combinations that can also be expressed as
(C) the relationship of pressure to the optimal acoustic modulation frequency for
spherical droplet generation as well as (D) the measured droplet breakoff as it
related to the optimized modulation frequency that is coupled to a given flow
rate.
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Figure 3.8 Single Channel Droplets in Air. Droplet imaging (corresponding to
the parameters measured in Figure 2.7 A-D) showing how different
frequency/flow rate combinations as well as solution viscosity (by comparing
buffer solution to higher viscosity 2% alginate solution) alters the volumetric
shape of the droplets generated in air.
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3.5

Chemistry and Collection for Stable Droplet Formation

Aqueous two-phase separation chemistry is investigated to produce a more
stable droplet formation environment and solidification by rigid body rotation.

Aqueous two-phase separation (ATPS) is a chemical phenomenon where
two high molecular weight polymers are mixed in water and form an emulsion
similar to the interaction when water and oil are mixed. ATPS systems of high
molecular weight poly ethylene glycol (PEG) and dextran (DEX) are the most well
characterized system. These systems have advantages over conventional oilwater emulsions because of cytocompatibility but have only been demonstrated to
form monodisperse droplets using microfluidics systems.11 Varnell et al.
demonstrated the ability to incorporate alginate into the disperse phase of a
PEG/DEX ATPS system and crosslink the disperse phase as it jetted in a
microfluidics device.12 We hypothesized that we could use a similar ATPS system
in our high-throughput droplet generating instrumentation and gain improved
control over the physical properties of the high-speed droplets generated with
single channel devices. In parallel, we also optimized the use of a rigid body
rotation system as the collection mechanism for these ATPS droplets.
The disperse (or droplet) phase is prepared by making a 4% w/v sodium
alginate solution in physiological buffer containing 150 mM NaCl, 25 mM HEPES
(Sigma-Aldrich), dissolved overnight, and pH adjusted to 7.4 using a high viscosity
pH electrode. A separate but equal volume of 17% w/v 8 kDa PEG (Sigma-Aldrich)
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is also prepared in physiological buffer. To combine these two solutions, they are
passed through a 0.45 µm Nalgene bottle top filter and stirred. Upon mixing, the
final weight percentages are 2% ALG and 8.5% PEG (Figure 3.9 A). The
continuous phase is composed of 1.67% w/v 500kDa DEX (Sigma-Aldrich), 1 M
CaCl2 in physiological buffer at pH 7.4 and was also sterile filtered using the 0.45
µm bottle top assembly (Figure 3.9 A). We performed some initial characterization
to be sure that this solution chemistry did indeed form an ATPS, to measure flow
rates of ALG/PEG in the device to make sure it was possible to use this highly
viscous composite biomaterial for acoustically modulated droplet formation with
the single channel device instrumentation (Figure 3.9 B and C), and to attempt a
crosslinking experiment using the stirring collection method. We found that
ALG/PEG is able to flow through nozzles down to 50 µm in diameter, can be
modulated into droplets in the air with an amplified signal, and (in the absence of
CaCl2) the disperse and continuous phase did separate in bulk and also formed
an emulsion upon vortexing. However, attempting to collect droplets from a single
channel device with the disperse phase flowing through the device and the
continuous phase stirring in the collection bath did not produce individual spherical
collected particles (Figure 3.9 B, right). Similar to the results reported above, this
observation further motivated our investigations into an alternative droplet
collection mechanism.
Thinking about high-throughput droplet crosslinking and why the collection
attempts investigated thus far had fallen short, a simple model was developed to
better understand the physics involved in the system. During droplet formation in
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Figure 3.9 Improved Single Channel Device Operations. (A) Schematic of
the ATPS chemistry, highlighting the ALG/PEG droplet phase stabilized against
the continuous DEX/Ca2+ phase. (B) Schematic of the droplet generating
instrument and phase separation, crosslinking of droplets by stirring. (C) Flow
rates of ALG/PEG compared to water as a reference.
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the air, the droplets of the dispersed phase travel downward in direction with a
linear velocity that depends on the nozzle diameter, the flow rate, and the acoustic
modulation/droplet generation rate of the flow stream (on order 100’s cm/second).
Then, as the droplets submerge into the solidification bath they undergo an
instantaneous change in speed and direction which we found influences droplet
morphology before full solidification has occurred and produces tear drop shapes.
A stirring collection bath has flow conditions that are (1) turbulent, and thus impose
unpredictable impact forces on the droplets as well as shear stress, and (2) difficult
to measure and calibrate in detail, making it challenging to achieve an accurate
and reproducible result. So, to simultaneously simplify the system and gain more
control over the environment in the crosslinking bath, a concept from classical
mechanics was used to enable a more tuned and laminar droplet collection. This
concept is that of rigid body rotation (RBR) where a solution (crosslinking fluid for
this case in particular) contained in a flask that is spinning at a high angular
frequency has centrifugal acceleration applied away from the axis of rotation and
reduced shear stress because of the absence of lateral shear forces.

13,14

We

hypothesized that the non-turbulent nature of the solution would aid in maintaining
a spherical particle geometry. The fluid acceleration towards walls of the flask,
(determined by the radius, angular momentum, and gravitational acceleration)
causes the fluid to take on a smooth parabolic shape with an increase in height at
the walls of the flask (Figure 3.10 B). The circumferential velocity of the spinning
solution at a radial position towards the wall of the flask can be easily estimated
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Figure 3.10 Rigid Body Collection. Characterization of the circumferential
velocity in the RBR using a flask and the driver set up described in Section 3.3.
(A) shows the gearing apparatus with driver belt and the spin characterization
used to determine the circumferential velocity at different driver settings in
(rev/min) for a 15 cm diameter flask. (B) shows the parabolic flow profile without
mixing and (C) shows the stir rod for localized mixing in the flask just before
droplet submersion.
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using the gear ratio of our spin apparatus and based on the radius of the spinning
flask (Figure 3.10 A).
After experimenting with many different sizes of flasks and volumes of
collection solution, it was found that a 19x10 cm (diameter x height) flask with 200
mL of collection solution provides the most controllable and stable environment for
high-throughput ATPS droplet generation. The system was calibrated by
measuring the revolutions per minute at different driver dial settings and using the
radial distance from the center of the flask to the droplet submersion location to
determine the velocity (Figure 3.10 A). In fact, the first time the experiment was
attempted, the constructed RBR system was so stable and uniform that the
droplets were submerging into the solution repeatedly in the exact same location
and ultimately created a ring of solidified gel rather than individual particles. So, a
localized mixing environment was implemented into the solution by placing a glass
stir rod into the solution at an angle just before the droplet submersion point,
introducing enough mixing to prevent droplet recurrences in the same submersion
location and solidify individual particles (Figure 3.10 C). Furthermore, the timing of
the system to produce individual solidified particles rather than instances of
doublet, triplets, or even beads-on-a-string morphologies is estimated to optimize
a parameter that reproducibly produces individual particles in collection. For
example, 100 µm diameter droplets with an acoustic modulation of 4 kHz will need
to move at least 2.5x their own length in 250 µs to create enough space in between
droplet submersions to prevent droplet piling. By manipulating flow rate and
frequency combinations, it was found that up to 600 µm of droplet spacing in air is
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possible and the best set parameter to guarantee collection of individual droplets
(Figure 3.11).

Figure 3.11 Characterization of Droplet Spacing in Air. Device parameters
for generating ALG/PEG droplets in the air with different spacings measured.
The bolded blue boxes highlight conditions that meet the ~600 µm spacing
required to produce individual solidified droplets. It is also worth noting that
optimal spacing appears to be a combined effect of flow rate and frequency.
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High-throughput droplets without cells have been generated and collected
rather successfully using the ATPS/RBR approach. The droplets were generated
using 20.2 PSI or a 2 mL/min flow rate with a piezoelectric driving signal amplified
to 40 V p-p at a modulation frequency of 4.78 kHz. The RBR had a circumferential
velocity of 1 m/s which was slightly more than double what the model predicted is
necessary for individual droplet collection. Using ImageJ analysis to measure the
geometric mean diameter (GMD) of the droplets, the population was found to have
an average GMD of 224 µm ±13 µm and an aspect ratio of 1.3 (n = 100). As
demonstrated in Figure 3.12, the collected particles are not perfectly spherical and
there are some instances of shear forces causing particle elongation into tear drop
shapes, however the GMD is within the diffusional mass transport limitation and
particles of this morphology could still be used as scaffolding constructs for cell
encapsulation and 3D cell culture.
Two conditions for cell encapsulation were investigated in the context of this
approach to droplet generation in air. A human-skin malignant melanoma cell line,
MEL28, was obtained from ATCC and cultured using standard 2D cell culture
practices. Briefly, cells are maintained in tissue culture polystyrene T-75 flasks
(Corning) with 15 mL of complete Minimal Essential Media supplemented with 10%
Cosmic Calf Serum and 1% Penicillin/Streptomycin (Hyclone) in an incubator at
37° C with 5% CO2 BAL AIR. MEL28 cells were harvested from dishes using 0.05%
Trypsin with 1 mM EDTA (Hyclone) digestion for 10 minutes, mixed into a single
cell suspension using complete media and counted using a Z1 Series Coulter
Counter. The cell suspension was pelleted by centrifugation at 1500 RPM for 10
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Figure 3.12 Rigid Body Collected Droplets. Brightfield microscopy of
ALG/PEG droplets collected in DEX/Ca2+ using the RBR collection mechanism.
Although particle sphericity is not perfect, the droplets are viable options for use
in cell encapsulation.
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minutes and resuspended with the physiological buffer of 150 mM NaCl, 25 mM
HEPES, pH 7.4 with 1 mM EDTA. The cells were spun down once more into a
pellet at 1500 RPM for 10 minutes and this time resuspended into 1 mL of
physiological buffer with an additional 1 mM EDTA to prevent premature calcium
ion crosslinking, taken up into an 18G needle/syringe (BD) and then added
dropwise to 5 mL of vortexing ALG/PEG. This 6 mL cell suspension is then mixed
into 39 mL of ALG/PEG to produce the final dispersed phase cell suspension with
a concentration of 1x106 cells/mL. This cell suspension is loaded into the pressure
chamber and droplets in air were generated as described above. However, with
cells added, stable well-shaped droplets are found to be generated under only
limited ranges of conditions. Two sets of partially stable droplet formation
conditions found were: (1) 20.2 PSI, ~2 mL/min, 6.28 kHz and (2) 25.3 PSI, ~2.2
mL/min, and 8.98 kHz with RBR collection spinning at 1 m/s with localized mixing.
In general, it was observed that adding cells to the droplet generation
process shifts the robustness of the droplet formation in air. The freeze-frame
droplets appear to be slightly destabilized as they transit in air, which suggests that
the shift in solution viscosity by the addition of cells or even just the presence of
cells in the solution alone influences the physical properties of high-throughput
droplet generation in air. Additionally, when attempting to collect this population of
cell encapsulating droplets by RBR, no spherical particles were captured. Instead
the collection for both cases of attempted droplet capture produced a diffuse and
shapeless gel (Figure 3.13).
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Figure 3.13 Attempted Cell Encapsulation. Images from left to right of
droplets with cells generated in the air under two conditions and an example of
what is recovered from collection by RBR droplet solidification.

80

3.6

Discussion and Future Directions
The high rate of droplet generation achieved by the acoustic high-

throughput droplet generation in air instrumentation platforms described provides
a substantial improvement in large-scale biocompatible droplet generation
compared to microfluidics and other droplet synthesis approaches. This new
method of generating droplets is optimized to provide frequency-flow rate matches
that enable real-time control of the droplet diameter during generation, with
examples of droplet generation in air down to 100 µm diameter using both complex
(dual channel devices, ATPS chemistries) and simplified (single channel devices,
RBR collection) methods. In dual channel device operations, we note that although
core/sheath droplet generation in air is robust and well characterized, further
optimization for particle capture and solidification is needed to fully realize the
potential implications of the new method. We expect that using a redesigned ATPS
solution chemistry (developed subsequently to this work and described in Chapter
4) with the dual channel device and instrumentation platform will enable the
generation of core/sheath droplets with stabilized interfacial surface tensions.
Attempting this in the future is hypothesized to produce core alginate droplets that
have a sheath cushioning layer. This construct might (1) produce stable
core/sheath droplets in air during transit and (2) serve to reduce impact forces and
shearing effects in collection by providing a protective layer to the core droplet
before full solidification is achieved in the collection bath. Similarly, the redesigned
ATPS chemistries of Chapter 4 could be applied to single-channel device
operations with RBR collection mechanisms. Here the droplets containing cells
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would be generated out of a solution with a higher viscosity, which supports more
stable droplet formation and can be acoustically modulated by an amplified signal
driving the piezoelectric transducer. Further, the composition of this system would
allow collection into an immiscible solution, which would enhance sphericity. Other
droplet collection methods, perhaps as in bioprinting and with more advanced
automation technologies could make the high-speed droplet formation amenable
to collection.
The work presented in this chapter has demonstrated very high throughput
production of biocompatible spherical droplets, but the ultimate long-term goal of
cell encapsulation in such droplets was not realized. In subsequent work,
presented in later chapters, that goal has been realized both in lower throughput
microfluidic constructs (Chapter 4) and higher throughput centrifugal droplet
generation methods (Chapter 5). In addition, in the course of that subsequent work,
a great deal more was learned about both ATPS chemistry and control of viscosity
in concentrated alginate solutions with added cells. In the future, these new
insights could be applied to the techniques of high-throughput acoustic droplet
generation in air presented in this chapter, with the potential of producing cellcontaining droplets using these methods.
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Chapter 4

Microfluidics Droplet Generation

The work in Chapter 4 is the basis of a manuscript in preparation titled “Acoustically
Assisted Droplet Generation using Water-in-Water Systems for Cell Culturing
Microgels” with authors: Jacqueline A. De Lora1*, Frank A. Fencl1*, Aidira Dora
Yajaira Macias Gonzales1*, Alireza Bandegi2, Reza Foudazi2, Gabriel P. Lopez1,
Andrew P. Shreve1, Nick J. Carroll1

* Indicates co-equal contributions
1University of New Mexico, Albuquerque, NM, USA
2New Mexico State University, Las Cruces, NM, USA
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4.1

Generating Droplets with an Improved Microfluidics Approach

A new microfluidics method for synthesis of size-controlled droplets useful for 3D
cell culturing is achieved by coupling acoustic modulation of flow with droplet
capture and solidification.

Alginate matrices produce a robust, exceptional and inexpensive
environment for 3D culture of mammalian cells, which is important in the
development of therapeutics for cancer as well as in the fabrication of synthetic
tissue by bioprinting.1-3 Composite alginate matrices are being investigated as
model biocompatible materials for cell culture because tunable compositions can
be engineered to imitate properties of natural extracellular polymers and promote
cell adhesion.3 Alginate-based biomaterials have previously been integrated into
droplet microfluidics to create droplets for 3D cell culturing. However, methods of
synthesizing these droplets by conventional microfluidic devices are limited in that
the drops are stabilized using oil-water emulsion solutions.4 Although perfect
spheres are produced by microfluidic devices owing to the high interfacial tension
between emulsions of oil and water within the channels, this combination of
immiscible fluids is not ideal for cell culturing because water soluble nutrients and
waste products are unable to diffuse through the oil phase to maintain a
homeostatic environment in the aqueous droplet. Additionally, biomolecules such
as proteins may be disrupted by denaturation upon exposure to the oil phase.5
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Introducing improved droplet fluidic methods to create uniform droplet
hydrogels for biocompatible 3D cell culturing applications is therefore necessary.
This new system uses acoustic force to break up an aqueous two-phase fluidic jet
into monodispersed droplets that are then captured and crosslinked for 3D
hydrogel formation and use in cell culture studies. The work emphasizes the lowcost adaptation of a household speaker (i.e. the working components removed
from the housing of a portable Bluetooth speaker) and glass capillary microfluidic
devices using alginate as a gelling agent within a DEX/PEG system to produce
stable 3D cell encapsulating hydrogel droplets.
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4.2

Biocompatible Device Operation Conditions

A new microfluidic aqueous two-phase system (ATPS) for 3D hydrogel synthesis
without the use of cytotoxic oils is presented and used to form stable emulsions
through droplet formation by integration of acoustic modulation.

When dissolved in water, certain multicomponent polymer solutions exhibit
phase separation related to thermal equilibrium and polymer properties that
include density.6 Of these polymers, dextran (DEX) and poly(ethylene) glycol
(PEG) exhibit phase separation at specific mass percent concentrations. This
phase separation of DEX and PEG enables the creation of immiscible droplets of
either phase after the solution is physically mixed and enriched. To prepare the
solutions for enrichment, 5% w/w of a 100mL aqueous solution of 550 kDa DEX in
25mM HEPES buffer, 150 mM NaCl at pH of 7.4 is dissolved thoroughly. A 17%
w/w 100mL aqueous solution of 8 kDa (PEG) 25mM HEPES buffer, 150mM NaCl
at pH of 7.4 is dissolved separately. The two clear solutions are added to a 200
mL glass separatory funnel, mixed thoroughly, and allowed to separate into
distinct, enriched phases at room temperature over 48 hours. The higher density
DEX-enriched phase separates as the bottom phase in the funnel with
approximately 24 mL final volume, giving it an approximate final composition of
≈25% DEX (w/w). The lower density PEG-enriched phase remains as the top
phase in approximately 176 mL of volume, with a final concentration of ≈9.4% PEG
w/w

(Figure

4.1).

The

estimated
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further

Figure 4.1 Biopolymer Enrichment. Experimental design for phase
separation, describing the initial polymer concentrations before enrichment (left)
and a diagram of the partitioned phases in bulk solution within a separatory
funnel.
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confirmed by measuring the index of refraction of the bottom phase and comparing
the value to a calibration curve of increasing w/w% DEX solutions ranging from 5%
to 30% DEX (Figure 4.3 F). A small fraction of DEX and PEG is, of course, also
present in the opposite phase at equilibrium (i.e., the DEX-enriched phase contains
a small amount of PEG, and vice versa). Even though both of these phases are
water-based, they are immiscible, including when injected into a co-flowing
microfluidic device.
After this equilibration process, the majority of each phase is then slowly
collected from the separatory funnel into separate vials, taking care to maintain
purity by separate collection and discarding of the interfacial region as necessary.
0.5% w/w alginate is added to the collected DEX-enriched phase and stirred for 24
hours for complete mixing. The DEX-alginate and PEG solutions are filtered using
a 0.2 µm Nalgene bottle top filter to sterilize for cell culture. Oil-water interfacial
tensions are on the order of tens of millinewtons/meter (mN/m), favoring stable
phase separation. In contrast, the DEX and PEG aqueous solutions exhibit a very
low interfacial tension on the order of hundreds of micronewtons/meter (μN/m),
requiring higher input energy to produce separation in microfluidic systems.5,7,8
Previous work has shown that incorporating these fluids in a microfluidic device
can lead to droplets only after a secondary physical force is applied to break up
the fluidic jet.9 This secondary force overcomes the low interfacial tension of the
two aqueous phases, enhancing droplet breakup in a co-flowing system. In this
new system, the secondary force is supplied by an amplified signal from a speaker
to cause the breakup of DEX-alginate surrounded by PEG continuous solutions
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Figure 4.2 Microfluidics Device Schematic. Integrating a speaker into the
microfluidics device operation enables break-up of the low interfacial tension
ATPS fluidic jet and provides control over the droplet size. (A) Syringe pumps
serve to inject the inner and outer phase fluids into the microfluidics device. (B)
The function generator/amplifier/speaker is coupled to the inner phase fluidic
line and oscillates at a frequency within a small tunable range to modulate
droplet formation in the device, which is observed in (C), with and without cells.
(D) The droplets are collected into a bath containing calcium ions, which
crosslinks the alginate in the inner phase. Subsequently, the cell-containing
droplets are transferred to suspension culture for up to 9 days where (E) cell
growth is observed (scale bar 100 µm).
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into droplets. By directly attaching the fluidic inlet of the inner phase to a speaker,
an acoustic oscillation force leads to downstream droplet breakup of a co-flowing
fluidic jet and produces spherical and highly monodispersed droplets with modest
throughput (Figure 4.2).
Specifically, the microfluidic glass capillary devices are built upon 25 x 75 x
1 mm Swiss glass slides. The fluidic channels are made using cylindrical
borosilicate glass capillaries (World Precision Instruments, 1.0 mm O.D.) pulled to
a taper with a Sutter Instrument Co. P-97 Micropipette Puller and filed with fine
sand paper to produce a 100 µm I.D. injection capillary and 200 µm I.D. collection
capillary. The injection and collection capillaries are housed in a 1.5 mm O.D.
Harvard borosilicate glass square capillary tube, with tapered/filed ends interfacing
in the center of the square tube. The ends of the square capillary are covered with
Probe Needles M919 plastic-steel syringe tips normal to the surface of the
horizontal orientation of the glass capillaries. A square pattern is cut on either side
of the syringe tips to snugly cover the capillary components of the device and then
sealed to the Swiss glass slide by applying Deycon Epoxy (Figure 4.2 C). The
capillaries are aligned using a Zeiss Axio brightfield microscope at 10X
magnification before the epoxy dries. The capillary ends and syringe tips are
coupled to Scientific Commodities, Inc. LDPE 1.3208 mm OD Micro Medical
Tubing and the device remains on the microscope stage for droplet synthesis. The
injection tubing, coupled to the injection capillary for inner phase infusion, is taped
directly to the dust cover surface of a household speaker. The speaker is
connected to a Fosi Audio Stereo Audio Amplifier Mini Hi-Fi Professional Amp for
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Home Speakers (50W 4 ohms, 20 Hz - 20 kHz, 0.04% THD) approximately 10 cm
from the microfluidic device. The signal source for frequency input through the
amplifier and into the loudspeaker is an Agilent Technologies 33250A
Function/Arbitrary Waveform Generator (Figure 4.2 B) where the initial input peakto-peak voltage is set to 10 V for all experiments. The inner phase injection tubing
is connected to a Becton Dickson 10mL plastic syringe and Harvard Apparatus
PHD 200 Infuse/Withdraw Syringe Pump approximately 74 cm from the
microfluidic device. The inner phase syringe contains the EMT6 mouse mammary
carcinoma cells (preparation described in Section 4.3) in ≈25% enriched 550 kDa
Dextran 25mM HEPES, 150mM NaCl, pH 7.4 with 0.5% by weight alginate (all
chemicals from Sigma Aldrich). The tubing connected to the outer phase infusion
syringe tip is connected to a Becton Dickson 60mL plastic syringe on another
Harvard Apparatus Syringe Pump approximately 80 cm from the microfluidic
device (Figure 4.2 A). The 60mL syringe contains the outer phase solution of ≈10%
enriched 8 kDa poly(ethylene) glycol, 25mM HEPES, 150mM NaCl solution at pH
7.4. The second syringe tip distal to the injection side is coupled with the same
Micro Medical Tubing and connected to a Becton Dickson 10 mL plastic syringe
for excess outer phase waste approximately 20 cm from the device. The collection
capillary is connected with a short 2.38 mm O.D. Tygon tubing to another 1.0 mm
O.D. World Precision Instruments borosilicate glass capillary with a ~90o elbow
that is submerged in a 20 mL Scintillation vial with a solution of 1 M CaCl2, 150
mM NaCl, 25 mM HEPES, and pH 7.4 crosslinking solution (Figure 4.2 D).
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The frequency/flow rate coupling within the device is determined by varying
the input waveform signal in 5 Hz intervals from 10 Hz to 60 Hz and the inner phase
flow rate across a narrow range to generate a lookup chart for optimized device
operation (Figure 4.3 A without cells and B with cells). Although certain frequency
and flow rate combinations produced polydispersed droplet populations (Figure
4.4 B and E), the droplet generation rate and average size of the droplets varies in
accordance with the flow rate and frequency parameters to produce
monodispersed droplet populations under many conditions (Figure 4.3 D, Figure
4.4 A without cells and Figure 4.3E, Figure 4.4 D with cells). Controlling the input
frequency and inner phase flow rate allows the user to manipulate the size of the
hydrogel droplets within the device. The droplets are sized for the longest axis
using Image J and the average diameter of at least n =3 is reported in Figure 4.3
D and E, error bars are smaller than the points. This effect of droplet size variation
by frequency modulation was observed in our preliminary work where enriched
PEG (outer phase) was co-flowed with enriched DEX (droplet phase) and
monodispersed DEX drops were formed. These observations motivated the idea
to use this method as a mode of generating monodispersed hydrogels for cell
culturing by incorporating alginate as a simple crosslinkable matrix for cell
encapsulation. Varying the weight percent concentrations of alginate drastically
changes the viscosity of the already highly viscous DEX droplet phase. High
concentrations of alginate inhibit the breakup of the inner phase even with
incorporation of an amplified signal to the loudspeaker. Scaling down the amount
of alginate to 0.5% in the DEX droplet phase enables droplet generation after
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increasing the amplitude of the applied acoustic force generated from the speaker.
Collecting the flowing droplets into a CaCl2 bath allows for rapid crosslinking of the
DEX-alginate gels which results in hydrogels with an almost perfect spherical
shape in some cases. After characterizing the DEX-alginate droplet generation,
the use of a model cancer cell line (EMT6 mouse mammary carcinoma) was
investigated to determine the efficacy of using this method for 3D cell culturing
over extended lengths of time.
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Figure 4.3 Characterization of a Microfluidic Device. Measurements across
a range of flow rate/frequency combinations both with and without cells have
been taken. Dispersity is characterized for frequency and flow rate
combinations (A and B) and monodispersed populations are sized as a function
of frequency (D and E). The solution rheology with and without cells is measured
across a range of shear rates (C), and the measured index of refraction for the
DEX-enriched phase is placed on a calibration curve to verify that the phase
separation produces DEX as the higher density, lower phase, with enriched
composition matching that estimated from volume changes (F).
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Figure 4.4 Device Operating Regimes. Microscopy examples of different
droplet generation regimes. Droplets with and without cells formed as
monodispersed populations (A and D, polydispersed regime (B and E), and
jetting/no droplet formation (C and F).

97

4.3

Cell Suspension and Encapsulation

Methods are developed for suspending cells in highly viscous DEX-alginate
solutions for droplet generation, collection, and subsequent suspension culture
for growth into spheroid-like structures.

The EMT6 mouse mammary carcinoma cell line is used for these
encapsulation studies. This cell line is well characterized to grow in conventional
tumor spheroid models in standard culture conditions,

10

and a protocol is

developed here for preparing a single cell suspension in the DEX-alginate droplet
phase. EMT6 mouse mammary carcinoma cells are maintained using standard
sterile cell culture conditions (37°C, 5%CO2) in 150 mm tissue culture treated
polystyrene dishes (Corning) with 20 mL of Minimal Essential Media supplemented
with 10% Fetal Bovine Serum and 1% Penicillin/Streptomycin (Sigma-Aldrich) to
grow up for encapsulation. The concentration of cells/droplet is easily adjusted for
desired occupancies by changing the initial cell encapsulation concentration. In
general, if desired cell/droplet occupancy is 10 cells/100 µm diameter droplet then
2x107 cells/mL is required for the encapsulation protocol. Cells at ~80% confluence
in 150 mm dishes (depending on the desired final concentration) are washed with
3 mL of 0.5% Trypsin and then incubated in 5 mL of 0.5% Trypsin (Sigma-Aldrich)
for up to 30 minutes to release attached cells. The cells are then washed off the
dish with gentle pipetting by adding 5 mL of media to the 5 mL of trypsin and cells.
This 10 mL cell suspension is transferred into a 50 mL centrifuge tube (and
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combined with cells recovered from additional 150 mm dishes if applicable), a
sample is taken for cell counting using a Z1 Series Coulter Counter and centrifuged
at 1500 RPM for 10 minutes to pellet. The cell concentration to be used is
determined, the cell pellet is resuspended into 20 mL physiological buffer (25 mM
HEPES, 150 mM NaCl, pH 7.4), and the volume corresponding to the desired final
cell concentration is transferred to a fresh 50 mL centrifuge tube. This adjusted cell
suspension is then centrifuged at 1500 RPM for 10 mins to wash and pellet. The
physiological buffer supernatant is then aspirated and the cell pellet is
resuspended into 500 µL of sterile filtered DEX-alginate by gentle pipetting using
a 1000 µL pipette. The 500 µL of DEX-alginate cell suspension is drawn up into an
18G needle/10 mL syringe (BD) and then added dropwise to 2.5 mL of DEXalginate in a 50 mL centrifuge tube while vortexing. The 3 mL cell suspension is
then passed through a 40 µm cell strainer test-tube filter insert (BD Falcon) into a
fresh 50 mL centrifuge tube to produce the final single cell suspension in DEXalginate. A sample is taken from this solution to count the final cell concentration
as there is some cell loss (roughly 5% of the population) during the protocol due
to the highly-viscous nature of the DEX-alginate and the filtering out of any cell
clumps. This dropwise vortex, mixing, and filtering of the DEX-alginate and cells
guarantees a single cell suspension which is paramount to avoiding clogs in the
microfluidics device. The cell suspension is loaded into the 10 mL syringe
described in Section 4.2 for droplet synthesis in the microfluidics system.
After adding the cells to the DEX-alginate phase, we operated the system
at various inner phase flow rate and frequency combinations to determine if the
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addition of the cells would affect droplet generation. The resultant matrix of droplet
generation with cells varies from that of the inner phase solutions without cells
incorporated (Figure 4.3 A and B). This observation motivated the investigation of
the rheological properties of the fluid components both with and without cells.
Rheological analysis was completed using a Discovery Hybrid Rheometer HR-3
with a 40 mm 2.0 cone plate and Peltier plate steel geometry for temperaturecontrolled experiments. The samples analyzed are as follows: (1) DEX-alginate in
physiological buffer with no cells, “low” 3x106 cells/mL, and “high” 3x107cells/mL
and (2) physiological buffer with no cells, “low” 3x106 cells/mL, and “high”
3x107cells/mL. Comparing the viscoelastic behavior of these solutions would
indicate whether an order of magnitude change in cell concentration affects
viscosity, which could hypothetically then affect the droplet generation capabilities
of the microfluidic device. Each sample was placed on the rheometer twice and
the experiments were repeated in triplicate per sample. The rheological
characteristics of the samples were analyzed with two different methods. The first
method is by frequency sweep with the angular frequency from 628 to 0.1 rad/s
and the second by flow ramp with shear rate from 0.01 to 1000/s. The Young’s and
Storage modulus as well as complex viscosity is calculated from the frequency
sweep test. The dynamic viscosity is obtained from the flow ramp test. The
variations in viscosity in the DEX-alginate groups as well as in the buffer groups
are within error of each other for each solution which leads to the conclusion that
the presence of cells in the droplet phase at both low and high cell concentrations
does not substantially change the viscosity (Figure 4.3 C). However, the droplet
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generation matrix with cells is still limited upon addition of cells (Figure 4.3 A and
B). This may be caused by an observed cell aggregation within the inner phase
solution over the duration of a droplet synthesis experiment. As mentioned in
Section 4.1, a well-known challenge with the interface of microfluidic droplet
generation and cell culture is the necessity for low volumetric flow rates, where
cells in a biomaterial suspension may be out of ideal culture conditions for up to
hours at a time. The aggregation of cells over time is a natural phenomenon that
has been exploited for conventional tumor spheroid formation11, but in our case,
influences the injection of the inner phase solution out of the glass microcapillary
and therefore changes the dynamic rate of flow affecting the droplet generation.
To demonstrate that our new method of 3D cell encapsulation with an ATPS
system and the time to synthesize enough droplets for relevant biological assays
is still a biocompatible approach, we measured the fraction of live to necrotic cells
recovered from the inner phase directly after droplet generation using a Propidium
iodide flow cytometric assay (Figure 4.5). Briefly, upon completion of droplet
synthesis we assay the cells from the remaining cell suspension in DEX-alginate
for necrosis by propidium iodide. The DEX-alginate cell suspension is compared
to LIVE and DEAD control populations. The LIVE cells are processed with
trypsinization into a single cell suspension and remain in complete media on ice
during the experiment while the DEAD control cells are generated by suspension
in 50% ethanol for 60 minutes at 37°C and 5% CO2 in the incubator. Once the
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Figure 4.5 LIVE/DEAD Assay. The results from a necrosis (propidium iodide)
flow cytometric assay indicate that the polymer solutions and the method to
encapsulate the cells are biocompatible and the slight elevation in necrosis in
the DEX sample in comparison to the live control is because of post processing
effects due to centrifugation of cells out of the DEX-alginate solution.
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DEX-alginate cell suspension has been in ambient conditions for the duration of
droplet generation (~2 hours), it is transferred to a 15 mL centrifuge tube and
diluted by the addition of physiological buffer to dilute the viscosity of the solution.
The suspension is centrifuged at 3000 RPM for 10 minutes. In this first wash, the
cells form a band towards the bottom of the test tube but have not yet been fully
pelleted, so ~5 mL of the diluted DEX-alginate is removed by aspiration and 5 mL
of physiological buffer is added and vortexed. The tube is centrifuged at 3000 RPM
for 10 minutes. This wash/centrifugation protocol is repeated once more to pellet
the cells at the bottom of the tube and remove as much residual DEX-alginate
solution as possible. The DEX-alginate-buffer supernatant is aspirated and the
cells are washed in 10 mL of physiological buffer followed by aliquoting into 4, 15
mL test tubes and centrifugation at 2000 RPM for 10 minutes. The staining protocol
is then followed as described in Alexa Fluor 488 annexin V/Dead cell apoptosis
Kit with Alexa Fluor 488 annexin V and PI for flow cytometry from Invitrogen, but
in this case only for necrotic cell death. The samples are analyzed (100,000 events
per group on the gated population) using an Attune NxT flow cytometer.
Quantitatively, there is no statistically significant difference between the live control
group and our experimental (cells in DEX-alginate) group for necrosis. There was
a small qualitative increase in the necrosis of the cells in the DEX-alginate however
this is likely due to rigorous dilution, washing, and centrifugation protocol
necessary to recover the cell population from the viscous DEX-alginate pre-gel and
not due to exposure to the biomaterial.
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Over the course of droplet synthesis (about once/hour), crosslinked droplets
are removed from the setup and allowed to settle in the 1 M CaCl2 buffer so that
the excess Ca2+ may be removed and the cell encapsulating droplets can be
transferred by gentle pipetting into a temperature equilibrated 125 mL spinner flask
bioreactor (Corning) with 125 mL of complete media adjusted to pH 7.4 with 25
mM HEPES. For the t0 initial time point, a 20 µL sample of droplets is pipetted onto
a microscope slide (VWR) and placed onto a brightfield microscope for imaging
using a Nikon camera and SPOT Basic software. Once the total cell encapsulating
droplet population has been transferred into the spinner flask bioreactor, the head
space is backfilled with 5% CO2 and placed onto a slow stir plate in a warm room
maintained at 37°C for the duration of the time course (9 days). Cells have been
encapsulated on 3 separate occasions to demonstrate the reproducibility of the
methodology and at days 3, 5, 7, and 9, samples are taken from the cultures for
imaging (Figure 4.6) as described above. At these times, the culture media is also
changed. In that process, the spinner flask bioreactor is removed from the stir
plate, allowing the droplets to settle to the bottom of the flask. Once settled, the
media is aspirated being careful to leave about 20 mL at the bottom so as to not
aspirate droplets and then refilled to a final volume of 125 mL with temperature
equilibrated complete media and backfilled as before. To validate a cell recovery
solution that can dissolve the alginate crosslinks and recover the cells into a
droplet-free suspension, on day 9 the total droplet population is collected by
allowing the droplets to settle and then aspirating the media until 20 mL of media
and droplets remain in the spinner flask. The 20 mL of droplets and media is
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pipetted into a 50 mL centrifuge tube and the droplets are allowed to settle once
more (~10 minutes). The remaining media is carefully aspirated and 20 mL of a
droplet dissolving buffer (0.5% trypsin, 50 mM sodium citrate, 25 mM HEPES, 150
mM NaCl pH 7.4) is added to the droplets in the 50 mL tube. The tube is incubated
at 37°C for 30 minutes with vortexing every 5 minutes to encourage dissociation
of cell aggregates. The recovered cells in dissolving buffer are then centrifuged at
1500 RPM for 10 minutes, resuspended into 1 mL of physiological buffer and
counted using the Coulter Counter. Although the data is relevant but not conclusive
due to the limitation of a small sample size, droplet dissolution and cell pelleting
was observed. This method will be applicable for quantitative growth rate studies
in the future.

105

Figure 4.6 Encapsulation and Proliferation Results. Encapsulating cells in
DEX-alginate droplets produces a reliable platform for cell proliferation and
eventual formation into multicellular tumor spheroids. EMT6 mouse mammary
carcinoma cell encapsulation was performed in triplicate at initial concentrations
(rows a, b, and c) and observed to proliferate up to the end of the culture time
course of 9 days. (scale bars 50 µm)
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4.4

Cell Growth Over Time in Droplets

Acoustically assisted droplet generation for cell encapsulation in a microfluidics
device is demonstrated to be a reliable method for controlling the initiation of 3D
cell cultures.

The viability of these microgels proved exceptional after 9 days of
suspension culture in spinner flask bioreactors. We demonstrated the robustness
of the system by encapsulating EMT6 cells on 3 separate occasions, imaged the
proliferation of each culture immediately after encapsulation and at 3, 5, 7 and 9
days, and developed a method to recover cells from the hydrogels for counting
(Figure 4.6). The cell counting results are not presented because of difficulties in
acquiring enough cells to count a sample above the limit of detection of the cell
counter. Having a large enough droplet population to then have enough cells in a
sample is a systematic limitation for microfluidics discussed before and so the
growth curve presented is qualitative. It appears that there is a lag phase in the
proliferation rate of the cells from initial encapsulation to day 3 which is likely
caused by a low cell encapsulation concentration (~10 cells/droplet) and the cells
being isolated from one another. Once cell-cell contact is established, the growth
rate appears to become more exponential and cellular aggregation as in tumor
spheroid formation is observed. Acoustically assisting water/water droplet
generation for 3D cell culturing hydrogels provides a low cost and reproducible
method to grow and study cell systems across multiple applications. This
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technology provides a robust method to generate 3D hydrogels for cell culture and
has the potential to be used alongside drug discovery platforms or for 3D printing
applications.
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4.5

Discussion and Future Directions
This work has demonstrated the design and implementation of a

technologically

robust

microfluidics

droplet

generating

platform

for

the

encapsulation and growth of cells. However, the overall throughput of the
microfluidics device operations is a concern when looking to employ these types
of systems for downstream biological assays. Although miniaturization can be
viewed as a cost-effective approach to using less material for greater experimental
output6,7, the small-scale channel dimensions (both in soft-lithography PDMS
designs and glass capillary microfluidic assemblies) limit volumetric flow rates to
the order of µL/hour. This flow rate translates to droplets being generated on the
order of about 10 droplets/second, depending on the viscosity of the solutions,
geometry in the device, external forces, and total flow rate. This droplet production
rate is considerably smaller than other platforms (such as those detailed in
Chapters 3 and 5), which must be taken into account when the droplet population
is intended for biological applications. Generally, growth curves and other flow
cytometric bioassays require recovery of 2x105 cells from 3D cell cultures per time
point for robust statistical analysis. In order to produce 1x106 droplets from a
microfluidics device with a droplet phase flow rate of 100 µL/hour it would take 10
hours plus device initiation, which is nowhere near the throughput required to
complete a curve that extends over 7 days. Because of this time limitation for
cytocompatibility, we only operated the device for 2 hours and were therefore
limited in the types of downstream biological assays possible.
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Generally speaking during device operations, the cells may be at room
temperature without gas or humidity control and likely out of a sterile environment.
Essentially, the cells suspended in the droplet phase would be out of cell culture
conditions for lengths of time that are not explicitly cytocompatible and possibly
cytotoxic depending on the cell line being used. Techniques to increase
cytocompatibility are being established. Examples include (1) having stringent
sterilization standards if the instrumentation cannot be setup in a biological safety
hood (which then also limits the types of cells one may use for encapsulation); (2)
building the entire system in a sterile incubator chamber; (3) if the instrumentation
must be under ambient conditions on the benchtop, sequential injection of the cell
containing droplet phase by integration of switch valves such that the cell
suspension being injected is only out of compatible conditions for a minimized time
period; and (4) parallelizing the device so that many side-by-side channels (on
order 100 channels/chip), all with the same task and branched fluidic injections,
are operated simultaneously to increase the throughput.
Our initial work provides a microfluidics platform with feasibility for scaling
up by incorporating higher volume microfluidics with an acoustic actuator to yield
larger, uniform populations of 3D cell encapsulating hydrogels. This method of
encapsulating biological components might also be used to trap biological
structures such as giant unilamellar vesicles (GUVs), which have notoriously
limited stability in vitro. 12 Finally, using this gentle method to encapsulate biological
components may prove to aid in study for drug discoveries since the alginate
matrix provides a biomimetic 3D matrix for cell growth.
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Chapter 5

Centrifugal Droplet Generation for Cell Encapsulation

Chapters 5 and 6 are the basis of a manuscript in preparation titled “Alginate
droplet generation for high-throughput cell encapsulation and formation of
multicellular spheroids using modified centrifugal synthesis methods” with authors:
Jacqueline A. De Lora, Jason Velazquez, James P. Freyer, and Andrew P. Shreve

University of New Mexico, Albuquerque, NM, USA
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5.1

Robust Droplet Generation by Centrifugal Synthesis

An improved high-throughput 3D culture method is presented using simple
alginate gelation chemistry to encapsulate cells in large and uniform droplet
populations produced by centrifugal force in a standard laboratory centrifuge.

Cell encapsulation in droplet-based alginate hydrogels is conventionally
divided into two general approaches. The first is direct droplet generation where
alginate is dispensed out of a nozzle (sometimes by pressure driven fluid flow),
forms droplets in an air gap, and submerges into a calcium solidification solution.
These types of platforms can achieve high-throughput droplet generation
depending on engineered enhancements to the system but are more complex in
construction. Implementation into the laboratory is difficult as the costly and
complex instrumentation comes with the need for a skilled user to operate.1 The
second is indirect droplet generation using microfluidic emulsion systems to form
droplets within microchannels using the difference in surface tension between two
immiscible fluids to generate droplets. Although more biocompatible chemistries
are being investigated to avoid the use of oils in these types of systems (Chapter
4), it is well recognized that the main drawbacks to microfluidic droplet generation
are complicated set-ups and low throughput.2,3 Recent studies have demonstrated
the potential for droplet generation with biocompatible chemistries by centrifugal
synthesis; this process uses centrifugal forces with in-house fabricated devices
and readily available laboratory equipment to produce large amounts of uniform
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droplets.4-6 However, these methods for droplet generation have yet to be fully
implemented for (1) the generation of cell-sized droplets that enable the
stabilization and study of biological components such as vesicles and proteins
outside the context of cellular compartmentalization; (2) the formation of spherical
constructs for the encapsulation of low cell occupancies; and (3) the generation of
instant multicellular tumor spheroids (iMTSs) by encapsulating high cell
occupancies (Figure 5.1). This chapter demonstrates the use of improved
centrifugal droplet generating device designs for the first instance of cell-sized
droplet generation by centrifugal force, cell encapsulation in size-controlled and
uniform calcium alginate droplet populations, and the generation of droplets that
contain enough cells to instantly form a MTS. The improved methodology, from
device fabrication and operation to establishing cell culture protocols, is easily
implemented into standard cell culture practices and accessible to a wide range of
laboratories interested in adopting 3D cell culture.
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Figure 5.1 Centrifugal Droplet Generation and Applications. General
design, implementation, and application space for centrifugal droplet
generation. Clockwise from top left shows a diagram of the high-level device
design and droplet generation by centrifugal force. Right panel shows both a
diagrammatic representation and microscopy of small droplets without cells, as
well as larger droplets with a low concentration of cells and with a high
concentration of cells. Bottom left is a concise description of the droplet
populations depicted in the panel on the right.
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5.2

Centrifuge tube assemblies and hybrid nozzle designs

Droplet generating centrifuge tube assemblies are designed with new hybrid
needle/glass capillary nozzles of various combination and diameters to produce
controllable and uniform droplets down to sizes not previously observed.

The droplet generating centrifuge tube assembly design is inspired by
previous centrifugal synthesis approaches.4 The general approach is to produce a
centrifuge tube that contains as a lower layer the catch/solidification solution, and
an upper layer as a pre-gel solution that will form droplets in air to be captured in
the catch solution. Implementation involves using two nesting tube layers (an inner
construct for pre-gel/nozzle attachment and a normal outer tube for the droplet
catch/solidification solution) assembled for integration into a swinging arm
centrifuge. The purpose of the nesting nature of the droplet device assembly is to
spatially separate a sodium alginate pre-gel solution in the inner (upper)
compartment from a CaCl2 crosslinking solution partitioned in the outer (lower) tube
until droplet formation in air has occurred. When centrifugal force is applied to the
tube assembly, the swing arm of the centrifuge positions the tube such that the
central axis of the tube assembly is orthogonal to the rotation axis. The solution in
the inner nested tube is then drawn through the inner tube nozzle under the force
of artificial gravity induced by the rotation. Droplets are formed that transit in air
and then submerge into the 1 M CaCl2 catch solution for solidification. The devices
are operated in pairs to balance the centrifuge during rotation. One should also
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note that the throughput of this system can be enhanced by simply operating
multiple paired devices in parallel, limited only by the number of positions available
in the centrifuge to hold tube assemblies.
Compared to prior work4, one improvement made here is to greatly reduce
or adjust the nozzle size of the tube assembly by threading a custom cut glass
capillary (pulled to a taper with a Sutter Instrument Co. P-97 glass capillary puller
and soldered to a defined diameter using a Narishige Microforge) over a blunt tip
14G needle (Integrated Dispensing Solutions) and applying epoxy to produce an
easily attachable hybrid nozzle. Previous work only used commercially available
needles as the nozzle component in device assemblies, and the smallest inner
diameter needles commercially available are 108 µm (Nordson EFD). With these
conditions, the smallest possible 4% ALG droplet diameter is limited to ≈300 µm.
In general, a mismatch in nozzle diameter to droplet diameter is observed because
of the highly viscous nature of the ALG. By fabricating in house glass capillary
nozzles with diameters down to 50 µm (depending on the application, diameters
down to 5 µm are feasible) and coupling these to blunt tip needles, customized
nozzles are easily attached to centrifuge tube assemblies and increase the range
of possibilities for nozzle diameter, which governs droplet diameter.
The inner nozzle attachment is built by first using a drill press to make a 15
mm ID hole in the center of the twist cap from a standard 50 mL centrifuge tube.
The plunger of a 10 mL Luer-Lok Tip syringe (BD) is removed and the casing is
smoothly cut using a Dremel tool to roughly 60 mm length (from needle attachment
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Figure 5.2 Device Schematic. Diagram of the centrifuge tube assembly
showing the design of nesting compartments to partition solutions in the inner
tube (sodium alginate) and outer tube (calcium chloride) in order to prevent
premature crosslinking before centrifugal synthesis. Additionally, the hybrid
nozzle is detailed along with the height parameter that defines the sphericity of
the droplets produced. If the distance is too long, the droplets will be oblong and
if too short a loss of individual particles is observed.
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to top). The inner nesting layer is achieved by inserting the 10 mL syringe into the
15 mm hole of the centrifuge tube cap, Luer-Lok in the downward position, and
arranging it to provide the desired height. The distance between the nozzle tip and
catch solution is an important parameter that determines the sphericity of the
solidified droplets. For example, if 2 mL of droplet precursor solution and 8 mL of
crosslinking solution are used (as is the convention for the work detailed herein),
then the distance between the catch solution and nozzle tip should generally be
between 3-6 mm for spherical droplets. This is measured by marking the catch
solution surface in the 50 mL centrifuge tube and attaching a hybrid nozzle to the
syringe Luer-Lok tip to estimate the distance between the catch solution surface
and the nozzle tip. Once the appropriate height is achieved, a thin layer of hot melt
adhesive is applied to permanently set the syringe in the cap (Figure 5.2).
For centrifugal alginate droplet production, recent investigations have
modeled and defined how the relationships between device parameters such as
the height between nozzle tip and catch solution surface, droplet solution viscosity,
and nozzle diameter directly affect the size distribution and shape of the droplets.4
During centrifugal droplet generation optimization with our new hybrid nozzles,
three operational states were defined depending on the centrifugal force applied
to the tube assembly (set as revolutions per minute on the centrifuge and flow rate
of the inner tube sodium alginate measured by displacement in mL per minute).
With hybrid nozzle centrifuge tube assemblies, the most important parameters for
producing spherical alginate droplets are the viscosity of the solution, the diameter
of the nozzle, and the acceleration of alginate solution out of the nozzle. When
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Figure 5.3 Droplet Generating Flow Regimes. Diagram showing the three
operational states observed in centrifugal droplet generation with a hybrid
needle/glass capillary nozzle design. Assuming the height parameter is
optimized and the nozzle diameter is constant, if the acceleration is too high or
if the solution viscosity is too low the jetting regime will dominate the operation
of the device. Likewise, if the acceleration and viscosity are not within a certain
range it is possible to create a satellite regime where droplets with a bimodal
size distribution are produced (usually with one population being close to the
desired diameter and the other being too small). When the parameters are
optimized, a range of centrifugal force may be defined for generating and
collecting a droplet population with a narrow size distribution and nearly perfect
aspect ratio, with the diameter of the droplet being directly correlated to the
acceleration of the device is generated and collected.
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these parameters are optimized, a range of centrifugal force is established and the
revolutions per minute during droplet generation will control the size of the particles
collected from the catch solution depending on the solution viscosity. When
operating the devices at suboptimal conditions, jetting and satellite regimes are
observed where strings of crosslinked alginate or a bimodal droplet size
distribution occur, respectively. The image inlay in Figure 5.3 demonstrates the
desired monodispersed droplet population.
For simplicity in the discussion below, the centrifugal spin speeds for the
centrifuge used to generate droplets (Eppendorf 5810 Centrifuge) are reported in
revolutions per minute (RPM), with ramp-up and deceleration times being an
accepted experimental error. As shown in Figure 5.4 A, the speeds in RPM can be
converted to an approximate acceleration that depends on the radial distance from
the center of the rotor to the location of droplet formation within the centrifuge tube
assemblies when the swing arm has moved into position under artificial gravity
(roughly 19 cm for the Eppendorf 5810). These values are included so that
individuals interested in adapting this technology to a different centrifuge model
can approximate the acceleration for their own apparatus. Droplet generation is
optimized by comparing both a 108 µm diameter needle and a 50 µm diameter
hybrid nozzle over a range of centrifuge spin speeds. These studies use sodium
alginate solution without cells to determine the parameters best suited for uniform
droplet shape and size, which will then be translated to cell encapsulation. All
solutions and chemicals used for droplet generation are designed with buffering
capacity, osmolarity, and sterility in mind to achieve biocompatible cell culture
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conditions (all reagents from Sigma Aldrich unless otherwise noted). In order to
prepare the centrifuge tube assembly pairs for operation, 8 mL of the crosslinking
catch solution (1 M CaCl2, 25 mM HEPES, 150 mM NaCl, pH 7.4, 0.2 µm sterile
filtered using Nalgene APES bottle top vacuum filter apparatus) is pipetted into the
50 mL centrifuge tubes. The nozzles to be used are connected to the Luer-Lok
attachment of the 10 mL syringe/screw top arrangements, carefully positioned into
the 50 mL tubes, and locked into place by tightly securing the cap to the tube
making sure to keep the assemblies upright. Then 2 mL of sodium alginate
solution, prepared by dissolving 4% w/v alginic acid sodium salt in physiological
buffer (25 mM HEPES, 150 mM NaCl) with vigorous stirring overnight and pH
adjustment to 7.4 using a specialized electrode for highly viscous solutions
(Orion Ross Sure-Flow pH Electrode with Sure-Flow Junction, ThermoFisher), is carefully and slowly pipetted into the syringe inner compartment. The
centrifuge tube assemblies are weighed to ensure the centrifuge rotor will be
balanced, adjusted as needed by removing fluid if one of the devices in the pair is
heavier than its counterpart, and loaded into the centrifuge swing arm
compartments for operation.
For the purpose of comparison and validation, a parameter matrix using the
smallest gauge needle commercially available (nozzle radius 54 µm) and the new
hybrid nozzle (radius 25 µm) design has been established using the centrifuge
tube assemblies described above. The devices were operated in pairs across the
range of centrifuge RPMs of 700-1500 (Figure 5.4 B) (along with flow rates
measured by displacement of the alginate out of the inner compartment as seen

123

Figure 5.4 Hybrid Nozzle Characterization. (A) The approximate acceleration
as it depends on RPM with our centrifuge is shown here as a reference for other
centrifuges. (B) Microscopy of droplets generated using centrifuge tube
assemblies comparing the use of a needle as a nozzle and a smaller diameter
hybrid needle/glass capillary nozzle at a range of centrifugal forces.
Qualitatively, the hybrid nozzle generates much smaller droplets at all speeds
and across this range never transitions into the dripping with satellites regime
as is the case for 1500 RPM and the needle. (Scale bars 200 µm)
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Figure 5.5 Hybrid Nozzle Optimization. (A) Flow rates measured (in
triplicate with standard error bars smaller than the point) by displacement of
4% alginate in the device assembly using a 50 µm hybrid nozzle and (B)
corresponding geometric mean diameter of particles produced across the
range of speeds (n = 25, standard error bars also smaller than most points).
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in Figure 5.5 A), which was established to be the range where droplets with a
relatively narrow size distribution are generated. The collected droplets are then
imaged using brightfield microscopy and a Nikon camera with Spot Basic
microscopy software. The droplet images are analyzed using an ImageJ batch
macro to determine the geometric mean diameter of each particle, the aspect ratio,
and the average size of the population (at least an n=25 for each size distribution
measured). The geometric mean diameter is calculated as the square root of the
product of the longest distance (major axis) and the shortest distance (minor axis)
across the surface of the particle in an image and is used to determine the
geometric droplet diameter (Figure 5.5 B). The aspect ratio is determined by
dividing the length of the major axis by that of the minor axis. A value of 1 indicates
perfect circularity (sphericity), and the population distribution is determined by the
average of the measured geometric mean diameters.
It is observed that as centrifugal acceleration (reported as spin speeds in
RPM) increases, the geometric mean diameter of the collected droplets becomes
smaller. Although both the needled and the hybrid nozzles operate within the same
range of speeds, the droplets generated with the hybrid nozzle have a much
smaller geometric mean diameter range and are some of the smallest values
reported using centrifugal synthesis. The generation of droplets with a 50 µm
hybrid nozzle/centrifuge tube assembly has been well characterized by flow rate
measurements and analysis of droplet populations. This droplet generation
technology is explored to push the size limit of droplets by fabrication of smaller
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hybrid nozzles and adapted for cell encapsulation as demonstrated in the
remainder of Chapter 5.
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5.3

Cell-Sized Droplets

Centrifuge tube assemblies with hybrid nozzles are used for the first time to
produce super small droplets with sizes on the order of a large cell.

Large populations of biocompatible droplets with a narrow size distribution
and geometric mean diameter on the order of a large cell (25-30 µm) are desirable
for cell-free applications and enzyme immobilization studies. Droplet-based
microreactors are being investigated as synthetic compartmentalization platforms
to be used for the isolation and stabilization of vesicles of all lipid-derived
architectures, for example giant unilamellar vesicles, multilamellar vesicles,
multicompartment vesicles, and phase separated vesicles.5,6 The main limitation
of these artificial cell systems in bottom-up synthetic biology approaches is that the
lifetime of the vesicles once formed is roughly 1 hour due to the large osmotic
differences that are required to stabilize the phases.7 Other applications for
populations of cell-sized droplets include uses in high-throughput drug screening,
biomolecule analysis (proteins, nucleic acids, amino acids, DNA), molecular
interactions, and drug delivery investigations all within a 3D biomimetic
environment.8 Until this work using hybrid nozzles with in-house nozzle diameters
fabricated down to 5 µm ID, centrifugal droplet generation had yet to be realized
as a robust platform for the generation of large, uniform populations of cell-sized
droplets that can facilitate studies in the application spaces mentioned above.
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The general design of the tube assemblies and hybrid nozzle is consistent
with the methods detailed in Section 5.2. The important modifications to note are
(1) the glass capillary is pulled with a long taper and soldered to 5 µm and 7 µm
diameters to be glued onto the blunt tip needles, and (2) the height parameter (the
distance between the solidification solution surface and the tip of the nozzle) is
found to be optimized at 3 mm. Experiments using a short-tapered glass capillary,
10 µm diameter nozzles, and heights up to 6 mm produced undesirable particle
geometries and are not shown here. Finally, the cell-sized droplets were found to
only be generated at higher centrifugal forces moving the highly viscous 4% ALG
solution out of a small diameter nozzle requires higher input energy. However, this
is not a limitation as most standard swing arm centrifuges can spin up to 4000
RPM, and it was also found that using 3% ALG solutions is an option that still
maintains a robust particle sphericity. This brief investigation of using hybrid
nozzles with centrifuge tube assemblies is a proof-of-principle study that
demonstrates the use of 5 and 7 µm diameter nozzles, 3 mm heights, and speeds
of 2500 and 3000 RPM to produce cell-sized droplets that can be used for cell-free
systems.
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Figure 5.6 Cell-Sized Droplets. Microscopy of droplets generated using
centrifuge tube assemblies comparing the use of small diameter (5 and 7 µm)
hybrid needle/glass capillary nozzles at two centrifugal forces (2500 and 3000
RPM). Qualitatively, the hybrid nozzle generates small droplets (25-30 µm
geometric mean diameter with an n = 10 for each analysis by ImageJ) at speeds
attempted thus far and has the potential to be improved with higher speed
centrifugal generation. (Scale bars 25 µm)
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5.4

Cell Encapsulation by Centrifugal Droplet Generation

Centrifuge tube assemblies using hybrid nozzle designs are used to encapsulate
cancer cell lines at low and high cell occupancies to demonstrate the use of this
platform for cancer biology applications.

The cell encapsulation method is necessarily a simple and rigorous protocol
in order to produce a biocompatible single cell suspension for droplet generation.
Achieving a single cell suspension is important for standardized cell culture
conditions as well as for homogeneity in the droplet population, and also helps
avoid cell clumping that will cause clogs in the nozzles. In addition, it enables
applications discussed in Chapter 6 by, for example, addressing the need for each
droplet to have effectively the same numbers of cells when initiating proliferation
experiments. Cell processing procedures for encapsulation have been established
that use buffers without Ca2+ to count, wash, and introduce single cell suspensions
into ALG pre-gel solution without prematurely crosslinking the gel. Using this
protocol, it is possible to control the initial number of cells/droplet starting from low
cell numbers up to hundreds of cells/droplet. In addition, cell processing
procedures and buffers for recovering and counting encapsulated cells over time
from crosslinked droplets have been designed. To achieve sizing of the droplets
generated in a population, bright field microscopy imaging and analysis with
ImageJ has been implemented. These protocols enable statistically relevant
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measurement of the average droplet geometric mean diameter generated with
encapsulated cells at low and high cell occupancy.
The centrifugal droplet assemblies are prepared as described in Section
5.2. The difference here is that the ALG solution added to the inner compartment
of the droplet generating assembly contains a cell suspension. In the low cell
occupancy experiments described herein, the human non-small cell lung
carcinoma cell lines A549 WT and KO for HIF-1α are used; and in the high cell
occupancy experiments, the human malignant melanoma cell line MEL28 are
used. All cell lines are handled using the same conditions (complete Minimal
Essential Media with 10% Cosmic Calf Serum and 1% Penicillin and Streptomycin
from Hyclone and 37°C, 5% CO2 in the incubator) and protocols for standard cell
transfers or preparation into single cell suspensions (using 0.25% Trypsin with
EDTA from Hyclone, referred to as “trypsin”) have been developed. Cells are
plated at low density and grown over 5 days on 150 mm dishes to grow up for
encapsulation. The dishes are trypsinized with 5 mL of trypsin for 20- 30 minutes
at 37°C, 5% CO2 in the incubator and suspended by adding 5 mL of media to
transfer the entire 10 mL suspension per dish into a 50 mL centrifuge tube. A small
volume is taken to count the combined cell suspensions and measure the
concentration of cells. The cell suspension is pelleted by centrifugation at 2000
RPM for 10 minutes. The supernatant is aspirated and the cell pellet is washed by
resuspending into 20-50 mL of a cell encapsulation buffer (1 mM EDTA, 25 mM
HEPES, 150 mM NaCl, pH 7.4), depending on the cell concentration to be used,
to sequester any calcium ions and prevent the generation of crosslinks when the
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cells are added to the ALG that could cause premature crosslinking. The cell
suspension in encapsulation buffer is then centrifuged into a pellet for the second
time at 2000 RPM for 10 minutes. The supernatant is aspirated once more, and
the cell pellet is resuspended in 100 µL of encapsulation buffer with gentle pipetting
up and down using a 1000 µL pipette tip. 400 µL of 4% ALG is added to the 100
µL of cells and mixed. This step is necessary as direct resuspension of the cell
pellet into 4% ALG produces a suspension high in cell multiplicity (doublets,
triplicates and larger cell clumps) because of the viscosity. By resuspending cells
into 100 µL of buffer (low viscosity) and adding dropwise into the ALG, clumps can
be broken up and a single cell suspension is achieved. This is important for uniform
distribution of cells in the droplets as well as to prevent clumps from clogging the
devices. This 500 µL of cells in ALG is then drawn up into an 18G needle/10 mL
syringe (BD) and added dropwise to 4.5 mL of 4% ALG while vortexing to produce
a 5 mL total volume single cell suspension. The 5 mL cell suspension is passed
through a 40 µm cell strainer filter mesh to remove any residual debris. Finally, 2
mL of the cell suspension in ALG is added to the inner compartment of centrifuge
tube device assembly pairs. This makes the final preparation for device operation.
A549 cells have been encapsulated at low cell density under two different
cell concentrations and operating parameter combinations in order to demonstrate
cell encapsulation across the range of frequencies in which we observed robust
droplet generation without cells. A549 KO and WT cells were each prepared for
low cell occupancy encapsulation as described above. Briefly, a cell suspension in
ALG of 4 x 105 cells/mL is used to produce cell encapsulating droplets using a 70
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Figure 5.7 A549 WT Droplet Distribution. (A) Microscopy of droplets
generated using 70 µm diameter hybrid nozzles in centrifuge tube assemblies
operated at 11000 RPM to encapsulate A549 WT cells. (B) Statistical analysis
showing the size distribution and other features in the table inlay of the collected
cell encapsulating droplets (n = 94).
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Figure 5.8 A549 KO Droplet Distribution. (A) Microscopy of droplets
generated using 70 µm diameter hybrid nozzles in centrifuge tube assemblies
operated at 700 RPM to encapsulate A549 KO cells. (B) Statistical analysis
showing the size distribution and other features in the table inlay of the collected
cell encapsulating droplets (n = 96).
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µm diameter hybrid nozzle and 1100 RPM or 700 RPM for the WT and KO,
respectively (Figures 5.7 and 5.8). Because the droplets were generated at
different speeds, they were measured to have different geometric mean diameters
and a slightly different cell occupancy (WT estimated 5 cells/drop and KO
estimated 10 cells/drop), which is itself governed by a Poisson distribution. The
aspect ratio of the particles is nearly perfect at 1.02. The coefficient of variation of
particle size is 2-3%, which indicates a narrow size distribution. To reduce or
eliminate the presence of significant intra-droplet concentration gradients during
cell culture, droplet size is an important consideration. Ideally, one might use
droplets of ≈200 µm diameter or less, and these droplets are larger than this (KO
392.1 µm diameter and WT 301.1 µm diameter). However, they are still within a
size range that is compatible with matching diffusional transport to metabolic
consumption, and the generation of substantial intra-droplet gradients is not
expected (especially for low cell occupancy numbers). Finally, these initial proofof-principle cell encapsulating droplet populations are generated using the lower
end of the centrifugal force range that was observed to produce monodispersed
droplet populations, so further investigation into low cell occupancy encapsulations
may produce even smaller particles.
High cell occupancy experiments are designed to produce droplets with
essentially the same number of cells as an early stage multicellular tumor spheroid,
forming an instant spheroid. The formation of scaffold-supported instant spheroids
is an application not yet realized in the field that could have major implications for
studying the chemical microenvironment, large particle flow cytometry, high-
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throughput drug discovery, and tissue engineering. The same device construction
and cell preparations are used as described in Section 5.2 and 5.4 with the main
distinction here being the cells for encapsulation were the MEL28 cell line and the
concentration to be encapsulated was largely scaled up using multiple 150 mm
tissue treated polystyrene dishes. A range of cell concentrations was investigated
to determine the maximum number of cells in 4% ALG able to flow through a 50
µm hybrid nozzle/centrifuge tube assembly. For high cell occupancy, the cell
distribution per droplet follows a near Gaussian distribution (large number limit of
Poisson distribution), so the encapsulated concentration and thus the cells/droplet
is a measure of the average number of cells expected to occupy a droplet. High
cell occupancies were achieved for droplets generated with a 50 µm diameter
nozzle at 1250 RPM producing ~230 µm diameter droplet populations for each of
the three successfully attempted encapsulations (n = 25, coefficient of variation of
2.6%) (Figure 5.9), and no droplets for the upper limit due to nozzle clogging and
a high multiplicity (cell clumping even after filtering through a 40 µm cell strainer)
in the cell suspension. Specifically, four cell concentrations were attempted for
encapsulation: (1) 1.6 x 107 cells/mL (100 cells/droplet); (2) 3 x 107 cells/mL (200
cells/droplet); (3) 6 x 107 cells/mL (400 cells/droplet); and (4) 8 x 107 cells/mL (500
cells/droplet), with the highest causing nozzle clogging. For the purpose of this
Chapter, the data displayed is exclusively from microscopy of instant spheroid
populations immediately after encapsulation. Additional studies and their results
are presented in Chapter 6.
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Figure 5.9 Instant Spheroid Formation. Microscopy of scaffold supported
instant spheroid formation using a 50 µm diameter hybrid nozzle/centrifuge tube
assembly operated at 1250 RPM. (Scale bar is 200 µm).
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5.5

Discussion and Future Directions
The improved method for droplet-based 3D cell encapsulation by centrifugal

droplet generation demonstrates an alternative technology that addresses the
limitations of microfluidic and droplet generation in-air platforms. A single
centrifuge tube assembly with hybrid nozzle has a moderate throughput on order
of 1000 droplets/second depending on the operating parameters, which in itself is
a significant improvement to microfluidics throughputs that are on order of 10
droplets/second. As mentioned previously, this moderate throughput in centrifugal
synthesis can enter the high-throughput regime by operating up to 16 centrifuge
tube assemblies in parallel (depending on the centrifuge). The centrifuge tube
assemblies, in a way, are to be included in the droplet generation in-air category
as the flow out of the hybrid nozzle and droplet formation under artificial gravity
occurs in an air gap that is an optimized parameter (3-6 mm height). Unlike droplet
generation in-air which typically uses a stirring or mixing droplet collection
mechanism with shear forces, the droplet collection in centrifugal synthesis is not
subjected to shear forces and therefore produces nearly perfect spheres (also
dependent on solution viscosity). The adaptation of this technology for cell
encapsulation requires protocol development and optimization (as described in
Chapter 6) however all studies are designed and constructed with readily available
materials that most biomedical research labs would have in house. Therefore, the
implementation of centrifugal droplet generating technologies into labs interested
in using 3D cell cultures to investigate cancer research questions is feasible.
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Chapter 6

Droplet-based Cell Encapsulation in Cancer Research
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6.1

Realistic and Standardized Approaches for Cancer Research

The disparity in translation observed between in vitro (2D and 3D model
systems), preclinical trials (animal models) and the results observed in clinical
trials is attributed, in part, to the unrealistic synthetic systems that are the current
standard in cancer research approaches.

In cancer research, treatments have been discovered that enable a drug
compound to be directed to a specific type of cell. Often, these approaches are
developed by using model cell-line screening processes or in vivo xenograft
models that identify unique genetic biomarkers (usually because of a single
mutation).1 However, these models have poor clinical translation because of a
systematic inability to mimic key pathophysiological features. For example, 2D
tissue culture conditions are entirely unrealistic in that tissue culture media
(concentrations of nutrients such as glucose, glutamine, and other essential amino
acids)2,3 as well as incubator conditions (oxygen levels in particular) are designed
to sustain mammalian cells on a dish rather than to mimic the physiologically
restrictive conditions of an in vivo primary tumor. In addition, 2D cultures lack
cellular, biochemical, and metabolic heterogeneity as well as the complexity of a
3D tissue microenvironment4, which directly influences the translatability of in vitro
drug screening. Xenograft models suffer from the limitations of the biology of the
mouse itself. In comparison to the human systems it is designed to mimic, the
mouse has a higher metabolic rate, is inbred, has a short lifespan, is reared in
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sterilized environments, and in immunodeficient mice, transplantable tumors grow
to treatment size over weeks (not years as is typical in humans).5 In comparison
to 2D cultures, xenograft models lack parametric control for mechanism of action
investigations, and in many cases the animal system is actually too complex for
meaningful controls. In addition, the use of monogenic human tumor cell lines in
xenograft models is lacking the genomic instability of a primary cancer and is one
of the main reasons why xenotransplantation data fails to translate to human
clinical results.6 Although recapitulating all of the pathophysiological aspects of an
in vivo tumor may never be fully realistic, there is a need to define a new paradigm
in tissue culture practices in order to implement new assay formats that mimic
more of the essential aspects of heterogeneity in human tumors.
The multicellular tumor spheroid (MTS) model is a 3D in vitro cell culture
system containing growth kinetics, cellular heterogeneity, nutrient and waste
gradients, hypoxia, acidosis, drug penetration, drug response/resistance, and
metabolic interactions mimicking that of an in vivo tumorigenic tissue.7,8 This
imitation of key pathophysiological conditions makes 3D cell culture an
improvement when compared to overly simplistic 2D tissue culture or overly
complex xenograft models. In fact, it is common opinion that intelligently designed
3D culture systems will bridge the gap between 2D and animal models.9 However,
there are practical drawbacks currently preventing 3D model systems from being
widely implemented between standard 2D cell culture and xenograft experimental
model systems. Conventional aggregation-based (or scaffold-free) spheroid
formation methods are limited in that the resulting MTSs have a polydisperse
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distribution, are low yield because of multiple factors (size selection to obtain a
population with the same sized spheroids, number of wells on a plate to form
spheroids etc.), are characterized by an inability to control cell ratios in co-culture
populations, and have a marked lack of standardized assays for evaluation
(proliferation tracking, viability, correlation to local biochemical microenvironments
etc.). Cell encapsulation by droplet generation to produce MTS templates
(scaffold-based using biomaterials) has been attempted using both in-air and
microfluidic platforms10-12, but generally falls short in terms of overall cost,
simplicity of device fabrication, high throughput operation, monodispersity,
biocompatibility, and recovery of cells for downstream assays.
The results presented in Chapters 4 and 5 have demonstrated droplet
generation with biocompatible chemistries by microfluidic (Chapter 4) or centrifugal
(Chapter 5) synthesis methods to produce uniform cell encapsulating droplets. The
studies shown in Chapter 4 specifically validated a qualitative approach to cell
encapsulation in droplets and growth over 9 days using spinner flask bioreactor
culture and verified that the method of encapsulation was not cytotoxic using a
LIVE/DEAD flow cytometric assay. These validation studies for 3D cell culture are
a good step in progress towards developing standardized evaluation methods.
However, as previously discussed, the microfluidics approach to cell encapsulation
is still technologically limited in certain aspects, especially throughput. In contrast,
the results in Chapter 5 demonstrate the use of centrifugal generation methods to
produce droplets with encapsulated cells in a relatively high throughput manner
and with excellent reproducibility. Therefore, in this Chapter centrifugal droplet
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generation is used to begin the process of demonstrating (1) the formation of
spherical constructs for cell proliferation tracking with the goal being comparison
to results observed in 2D monolayer cultures; (2) the generation and culture over
time of scaffold-supported spheroids and instant MTSs (iMTS); and (3) the
culturing of cells in encapsulating droplets in altered chemical environments
(Figure 6.1). The work here uses mouse and human cancer cell lines with a
wildtype +HIF-1α phenotype (WT) and knockout -HIF-1α phenotype (KO), HKO3TR and A549 respectively, as well as human MEL28. The use of these cell lines is
relevant to the biomedical hypothesis posed in Chapter 1 so that discussion of the
methods in progress are ultimately tied to a significant question concerning the
interaction of pH, oxygen, and HIF-1α.

146

Figure 6.1 Droplet-based Bioassay Applications. Summary of the
approaches in development for the standardization of evaluation methods used
to measure proliferation of droplet encapsulated cells, culturing of scaffold
supported templates for spheroid formation, and the use of cell encapsulating
droplets in altered environment experimental designs.
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6.2

Adapting 2D Growth Assays to 3D Cell Culture

New methods are needed to measure the proliferation of cells encapsulated in
droplets and to improve 3D cell culture evaluation methods to achieve more
realistic measurements of cell growth.

The doubling time of a cell culture is the fundamental measure of the period
of time it takes for a cell to undergo one cell cycle, resulting in the replication of
DNA and cell division to produce two new daughter cells. The quantity is used in
cancer research to describe the average growth rate of a cancer cell population
over time in vitro. However, in 3D cell cultures, the situation is more complex. A
length vs width method is used to measure the geometric mean diameter of
multicellular spheroids by simply using a microscope reticle to measure a
population of spheroids over time. This reports the growth of a spheroid
population13, but does not directly measure the discrete growth of cells within the
spheroid, does not take into account cell death by either apoptosis or necrosis,
and there is currently no measurement techniques to analyze biochemical gradient
information. In preclinical and clinical studies, the volume of a tumor oftentimes
provides qualitative insight to the stage and malignant potential of the tumor as
well as treatment efficacy when the tumor size is observed to shrink.14 Depending
on the location of the tumor in vivo, measurement of the tumor can be achieved in
situ by using calipers to take the length versus width and calculate the tumor
volume as an ellipsoid, which provides a measure similar to the multicellular tumor
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spheroid but, again, is not a discrete measure of the proliferation rate of the cells.
Although non-invasive imaging is the gold standard for measurement of tumor
volume in vivo15, it is expensive and oftentimes logistically unrealistic to apply
these techniques to the routine measurements of in vitro 3D cell cultures. It is
therefore desirable to develop quantitative proliferation measurement techniques
that are inspired by the inexpensive and in-house nature of standard 2D cell culture
methodologies but that are adapted to handle the increased complexity of sample
processing to measure the growth of cells within a droplet scaffolding biomaterial.
The conventional method for measuring the doubling time of a 2D
monolayer cell culture is by counting cells over time. However, recently, a class of
membrane-intercalating fluorescent reporter molecules have also been used to
measure the doubling time of cells grown in 2D cell culture.16 These fluorescent
molecules have a lipophilic group attached to the fluorophore and insert into the
lipid membrane of cells at an initial high concentration and thus intensity when
measured by flow cytometry. When the cells divide, the fluorescence intensity per
cell reduces to half of the initial value, and therefore the fluorescence dilution by
half is a measure of the doubling time of the stained cell population. This method
of measuring fluorescence dilution by flow cytometry is useful in that cells in a
coculture can be stained with different colored fluorophores and be differentiated
from one another.
In order to benchmark our ultimate transition of these methods to 3D
cultures, an initial detailed study is performed using these combined methods of
standard cell counting and fluorescence dilution to measure the doubling times of
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the HKO3 WT, HKO3 KO, A549 WT, and A549 KO cells in 2D mono- and cocultures. The standard cell counting growth curve analysis is combined with the
fluorescence dilution assay for these experiments to have a method for
differentiating the WT cells from KO cells in a coculture. The growth curves and
fluorescence dilution experiments are initiated by culturing enough cells (using the
cell culture protocols and materials detailed in Chapters 4 and 5) to yield 2 x 107
cells for staining with either green reporter molecules, known as PKH 67, or red
reporter molecules, known as CellVue Claret Far Red (SigmaAldrich, all staining
protocols are followed as published in the technical bulletin). To establish the
convention, the groups for both the HKO3 and A549 cells are consistent and as
follows: (1) WT monoculture labeled green with PKH67; (2) KO monoculture
labeled red with CellVue Claret Far Red; and (3) 50% WT green and 50% KO red
mixed evenly to produce the coculture.
The actual cultures are initiated by inoculating up to 30 tissue culture treated
dishes (60 mm diameter) with the same lower cell concentration to establish the
cell concentration per dish at t0 for each of the WT, KO and 50WT/50KO groups
using both HKO3 and A549. The cells in the dishes are grown in standard culture
conditions and sampled in triplicate by trypsinization to obtain a cell suspension,
counted using a Z1 Coulter Counter at determined time points for the duration of
the experiment (5 days HKO3 and 10 days A549) to measure the number of cells
per dish, as well as measured by flow cytometry using an Accuri C6 Flow
Cytometer to obtain the mean fluorescence intensity over time (methods depicted
in Figure 6.2 A and expected outcomes for growth curve in Figure 6.2 B as well as
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Figure 6.2 Growth Assay Methodologies. Summary of the growth and
fluorescence dilution protocols. Following the 2D arrows shows the procedure
for using the established protocols to track mono- and co-cultured cell
proliferation in monolayers. Following the 3D workflow arrows details the
general protocol for adapting the method to 3D cell culture using droplet
encapsulated cell populations (A). An example of a typical growth curve is
depicted in (B) with the different phases in growth. The fluorescence dilution
curve is depicted in (C) showing the decrease in the fluorescence intensity
signal per cell over time as the cell population exponentially increases.

151

fluorescence dilution curve in Figure 6.2 C). The data is collected and plotted as
growth curves by number of cells per dish over time and as fluorescence dilution
curves by the mean fluorescence intensity value per cell measured over time. For
completeness, each growth and fluorescence dilution curve is executed in parallel
with control groups that are unstained but still follow the convention set using each
cell line. Figures 6.3 and 6.4 show the HKO3 and A549 WT, KO and Coculture
experiments respectively, with the growth curves on the top row, the fluorescence
dilution curves on the bottom row, and each point is an averaged measurement
from 3 samples with error bars that in most cases are smaller than the point itself.
Each plot has a curve in green for WT, red for KO, and blue for the unstained
control.
Although the growth curve coculture (Figure 6.3 E and 6.4 E) should only
have one curve because the cells cannot be differentiated by simple counting, it is
possible to use the flow cytometry data to determine the percentage of each cell
type in the coculture and plot the resulting values as a growth curve. Specifically,
the coculture is counted over time as cells/dish with no distinction between the red
and green cells by the cell counter (black line). The coculture population is
subsequently measured by flow cytometry where the mean fluorescence intensity
is measured in two channels for the two colors of dye used with each cell type over
time. In analysis, a gate is set around the population of cells in each green and red
channel that provides the percentage of cells of that relative color within the total
population. The cells/dish value is then multiplied by the percentage of either green
or red cells and this value indicates the number of cells in the dish that are either
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Figure 6.3 HKO3 2D Growth Assay Results. Growth and fluorescence dilution
assay of HKO3 WT (green), KO (red) and Cocultures. All time points are done
in triplicate and error bars are smaller than the point in all cases. The doubling
and decay times in hours for mono and cocultures are indicated as inlays for
the growth curves in A, C, and E and fluorescence dilution curves in B, D, and
F. The blue lines indicate the measurement of unstained control groups, which
are a measure of autofluorescence in the fluorescence dilution curves.
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Figure 6.4 A459 2D Growth Assay Results. Growth and fluorescence dilution
assay of A549 WT (green), KO (red) and Cocultures. All time points are done in
triplicate and error bars are smaller than the point in all cases. The doubling and
decay times in hours for mono and cocultures are indicated as inlays for the
growth curves in A, C, and E and fluorescence dilution curves in B, D, and F.
The blue lines indicate the measurement of unstained control groups, which are
a measure of autofluorescence in the fluorescence dilution curves.
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green or red. These values are then plotted as green and red curves on the
coculture growth curves.
The doubling times and fluorescence decay times in hours are reported as
inlays on their respective plots. In some instances, the growth curves demonstrate
exponential growth and a plateau phase (Figure 6.3 A, C and E) whereas in other
instances there is a faster transition to the cell death phase (Figure 6.4 A, C and
E). In the fluorescence dilution curves, the length of time that cell division can be
monitored is limited by the autofluorescence of the cell line. For example, there is
an order of magnitude difference between the fluorescence intensity of the stained
populations in comparison to the unstained control groups in Figure 6.3 B, D and
F even after the plateau phase is reached. In contrast, Figure 6.4 B demonstrates
a case where the fluorescence dilution signal intensity eventually decays to the
same level of the autofluorescence of the unstained cells, and so time points past
that level are no longer useful in determining the doubling (decay) time. To
summarize, each cell line doubling time was calculated for the instances of cells
grown in both mono and co-cultures.
Although the cells were grown in 2D monolayer cultures in culture
conditions designed to support cell growth, the methods described for culturing
and measuring cell growth in mono- and co-culture above demonstrate a robust
and validated approach. Similar methodology is now needed to implement 3D cell
culture into standard lab practices. The remainder of this section focuses on the
development and proofs of principle of such methodology in order to take a step
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towards using cell encapsulation in droplets as a more robust method for
measuring cell growth.
Initially, unstained A549 WT and KO cells were encapsulated at low cell
occupancy in droplets using 70 µm diameter hybrid nozzles and two different
centrifugal forces (1100 RPM for WT, and 700 RPM for KO) as described in
Chapter 5, to produce a proof-of-principle experiment for a 3D growth curve. The
droplets collected in the catch were washed using physiological buffer (25 mM
HEPES, 150 mM NaCl, pH 7.4, SigmaAldrich) and then pipetted into a 125 mL
spinner flask bioreactor (Corning) containing 125 mL of complete Minimal
Essential Media (10% Cosmic Calf Serum, 1% Penicillin/Streptomycin, Hyclone)
with an added 25 mM HEPES, pH adjustment to 7.4, and 5% CO2 gas backfilled
into the head space to enhance the buffering capacity of the culture conditions for
the experiment. The cell encapsulating droplets were then cultured in the spinner
flask on a low speed magnetic stir plate (VWR) in a warm room at 37°C for 7 days
with daily sampling for observation using brightfield microscopy and media
changes every 24 hours (Figures 6.5 and 6.6). For a media change, briefly, the
spinner flasks are removed from the stir plate and droplets settle to the bottom of
the flask over ~20 minutes. The spent media is aspirated, fresh temperatureequilibrated medium is replaced up to 125 mL in the flask, and the flask is placed
back into suspension culture conditions in the warm room. The resulting data
presented in Figures 6.5 and 6.6 is at this point primarily qualitative and a
demonstration that over 7 days in culture, the droplets are acceptably stable and
the cells show some proliferation at later time points (especially with the WT). For
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Figure 6.5 A549 WT Qualitative 3D Growth Assay. Qualitative growth curve
using microscopy of A549 WT cell encapsulating droplets generated by
centrifugal droplet synthesis from a 7-day growth experiment to observe droplet
stability and cell growth over time. The population is analyzed using ImageJ to
measure the geometric mean diameter, standard deviation, aspect ratio, and
coefficient of variation of the culture.
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Figure 6.6 A549 KO Qualitative 3D Growth Assay. Qualitative growth curve
using microscopy of A549 KO cell encapsulating droplets generated by
centrifugal droplet synthesis from a 7-day growth experiment to observe droplet
stability and cell growth over time. The population is analyzed using ImageJ to
measure the geometric mean diameter, standard deviation, aspect ratio, and
coefficient of variation of the culture.
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quantitative cell counting to be implemented into daily time points, the initial
concentration of the cells/drop should be measured at t0 and the concentration of
droplets in the 125 mL spinner flask bioreactor should be estimated to make sure
that a large enough population of cells is recovered from droplets at each
subsequent time point such that the cell count is above the limit of detection of the
cell counter and the number of cells/droplet can be approximated. These types of
measurements are quite feasible, as recovering the cells from the droplets is a
very straightforward chemical dissolution process where the droplets with cells are
washed using a 0.5% trypsin, 50 mM sodium citrate, 25 mM HEPES, 150 mM NaCl
pH 7.4 dissolution buffer for 20 minutes and centrifuged at 2000 RPM for 10
minutes to pellet the cells. The pellet is resuspended in PBS and cells are counted
on the Coulter Counter. Validation studies have been accomplished where a cell
population is counted before and immediately after cell encapsulation to
demonstrate reproducible recovery of 98% of the cell population indicating minimal
cell loss. This same protocol is used in the experiments described below to recover
cells from droplets for measurement of the cell population by flow cytometry.
An additional proof-of-principle study for the use of membrane fluorescence
dye dilution curves to measure the doubling time of cells encapsulated in a 3D
coculture has also been completed. Referring back to Figure 6.2, the cell
population to be encapsulated is stained with the respective fluorophore before
centrifugal droplet generation. An important experimental note is that the wash
steps after staining but before the cells are processed into a single cell suspension
in 4% ALG pre-gel are extremely important in this instance, as they are required
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to remove all residual fluorescence staining buffer included with the kits known as
“Diluent C”. This additive is intended to help increase efficiency of cell staining, but
even small residual amounts can cause slight foaming of the alginate solutions
and negatively interferes with droplet generation. Thus, for the studies shown here,
two extra wash steps are implemented into the protocol using the standard
physiological buffer. Figure 6.7 presents flow cytometry results obtained from
measuring A549 WT and KO cells in a 50/50 coculture before encapsulation into
droplets by centrifugal synthesis and after encapsulation by the recovery protocol
detailed above. Although a full growth curve analysis has not been completed,
these proof-of-principle studies, together with the qualitative 3D growth curve
results, demonstrate the feasibility of adapting two robust and standardized 2D cell
growth rate assays for use in droplet-based 3D cell cultures. These methods are
an improvement over conventional methods used to measure multicellular
spheroid growth.
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Figure 6.7 Coculture Proof-of-Principle Results. Flow cytometry of A549 WT
(green) and KO (red) cells stained, mixed into a coculture and encapsulated by
centrifugal droplet synthesis. The top panel is the fluorescence measured on
the coculture cell population before encapsulation. The bottom panel is the
fluorescence measured on the coculture cell population recovered from the
droplets. Each plot has two distinct populations because of the coculture nature
of the experiment where the fluorescence of the dye in one channel is distinct
from the autofluorescence of the cells labeled with the opposite dye. This
distinct measurement of labeled cells and autofluorescent cells is possible
because of the spectral separation of the dyes used in the experiment.
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6.3

Culture of Instant Spheroids

Cell encapsulated droplets using centrifugal synthesis and hybrid nozzles at high
cell occupancy concentrations produce scaffold-supported instant
spheroids that are stable and show cell aggregation in suspension culture
over 7 days.
The technical ability to generate large, uniform populations of multicellular
tumor spheroids generated by droplet-based methods has the potential to enable
wide-spread use of 3D culture in place of less realistic alternatives. There is an
economic trade-off between the supplies and equipment needed to generate and
maintain 2D vs 3D cell cultures and if consistent 3D culture methodology becomes
accessible, it is feasible to envision an enduring shift in the cancer research
paradigm to more realistic in vitro model systems. This section builds on the instant
spheroid cell encapsulation discussed in Chapter 5, and the MEL28 encapsulation
preparation at high cell occupancy used here is exactly as described for 200
cells/droplet in Section 5.4. The 50 µm hybrid nozzle/centrifuge tube assembly is
operated at 1300 RPM to produce droplets that had an average geometric mean
diameter of 230 µm. Then, the instantly formed spheroids are washed out of the
catch solution by allowing the droplets to settle, aspirating the solution,
resuspending in 15 mL of complete media and transferring the droplets over to a
spinner flask prepared as described in Section 6.2. The instant spheroid culture is
maintained for 7 days with intermittent sampling to observe cell behavior in the
droplets and daily media changes to maintain a stable culture environment. At day
7, there appears to be proliferation and marked aggregation of cells within the
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droplet (Figure 6.8). Adapting the 3D growth curve and fluorescence membrane
dye dilution curve described in Section 6.2 to measure the proliferation rate of cells
in an instant spheroid is a logical and important next step for the further validation
of this proof of principle experiment.
The technical ability to generate large and uniform populations of these
types of cell encapsulating constructs is important for applications in highthroughput drug screening. It can take up to weeks to generate a 3D spheroid
population depending on the conventional methods of formation and even then,
there is likely heterogeneity in the size distribution of the population. In contrast, it
takes a few hours to form a 3D cell culture population that has excellent uniformity
in size and control over the cell concentration using the centrifugal synthesis
method described in Chapter 5. These instant spheroid populations are more
realistic models of a tumor and enable high-throughput drug screenings that are
amenable to personalized medicine applications because of the quick processing.
The ability to coculture in 3D applications is important for building higher order
biomimetic structures that move towards an even more realistic model system.
Different cell concentration ratios of genetic variant cells or tumor/stromal cells can
be encapsulated and 3D cocultured. This enables the culture of mixed cell
populations in identical 3D microenvironments where competitive growth rates can
be measured. As growth assays are developed and standardized in 3D culture
applications (i.e. the use of multicolored fluorescence dye dilution assays which
are only limited by the colors available to stain the cells and the capability of the
flow cytometer to conduct a multicolor assay), one can envision the generation of
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multi-cultures where more than 3 cell types are encapsulated and tracked over
time, which has applications at the interface of multidisciplinary fields such as
immunology and cancer biology.

Figure 6.8 Instant Spheroid 3D Growth Assay. Microscopy of cell
encapsulating droplets formed with high cell occupancy (~200 cells/droplet at
t0) and grown in spinner flask suspension culture over 7 days. Qualitatively,
there is no difference in the first 24 hours of suspension culture. After 48 hours,
the cells begin to proliferate and aggregate, likely entering into an exponential
growth phase and after 7 days, the aggregation is more pronounced. This
experiment provides a proof-of-principle result for high cell occupancy cell
encapsulation and growth in suspension culture and can now be expanded with
implementation of quantitative measurement methods.
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6.4

Altered Chemical Environments System

An inexpensive, controlled, closed bioreactor system is designed to culture cells
in 3D environments in combinatorial oxygen and pH environments to begin the
process of investigating cellular responses to hypoxia and acidosis as mediated
by HIF-1α.
By now it has been well established that current cancer research model
systems, especially in 2D, do not realistically represent the biochemical
microenvironment. Culture media formulations and incubation environments are
designed to provide cells with (1) the minimal essential nutrients (glucose, amino
acids) required to keep cells alive ex situ; (2) a sodium bicarbonate buffering
system that is used to stabilize pH but can interact with other synthetic buffering
systems; and (3) ambient oxygen levels that are highly nonphysiological (~21%)
in comparison to a tissue (2%-9%). It goes without saying that these media and
incubation conditions are nothing like the altered environmental conditions in a
tumor that also exist with higher levels of complexity (e.g., with concentration
gradients imposed) in 3D. This section describes initial steps and challenges
towards the design and implementation of the technical ability to establish altered
environmental conditions for droplet-based 3D cultures. The overarching goal is to
design 3D discrete environment experiments with the ability to investigate the
biomedical question discussed in Chapter 1 (Figure 6.9 depicts the 4 groups of
interacting environmental parameters as well as the proposed response variables
to be measured for each cell line, A549 WT and KO).
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Figure 6.9 Experimental Design for Altered Environments. The left is a
drawing of the combinatorial pH and oxygen environments to be established
with A549 WT/KO cells encapsulated by centrifugal droplet generation and
cultured in suspension for 24 hours. These environmental conditions establish
the parameter limits for cell culture and will be amenable to establishing a
functional culture system as well as provide the control groups for further
investigations into the response surface. The right is a detailed list of the
possible response variables and features to be measured on cell populations
after recovery from droplets exposed to the altered environments. For the
purpose of this dissertation, this list is simply an example of standardized
experimental parameters that will enable the correlation of environmental
parameters to cellular physiology.
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The system designed to enable altered environment experiments is
inexpensive and simple but allows comprehensive investigation of conditions so
that stable cultures may be run in parallel under different environments. In addition,
collection and processing of samples is easy as well as sterile. The bioreactors are
constructed using 500 mL glass flasks (VWR) with modified caps to implement
tubing ports for gas flow into the head space of the flask, a sampling line, and an
off-gas line. All tubing and connectors used are selected to have low oxygen
permeability so that leakage into the gas line during anoxia experiments is not an
issue. Moreover, these components meet the specification of being sterilizable by
autoclaving (Tygon E-3603 1/4” and 1/16” hose barb size/autoclavable and
connectors from Cole-Parmer). The gas flow line is simply 1/4” ID tubing tightly
threaded through a drilled hole in the cap and measured so that the tubing end is
suspended above the media level in a flask during an experiment. The sample line
is a 1/16” ID tubing threaded through a second hole drilled into the cap and
measured to extended to the bottom of the flask. The exterior end of the tube is
connected to a hose-barb Luer-Lok connector threaded onto a 10 mL syringe (BD)
so that samples may be drawn up into the syringe without disturbing the
equilibrated culture environment during an experiment. Finally, the off-gas line is
made by drilling a third, small hole in to the cap and inserting an 18G needle. A 10
mL syringe with a small piece of cotton and without the plunger is attached to give
a gas permeable buffer zone for the off-gassing while maintaining a sterile
environment. Simple estimates of gas flow conditions and diffusional transport
verify the ability to maintain equilibrated anoxic (or reduced oxygen) environments,
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Figure 6.10 Experimental system for altered environments. Top is the
drawing of the system and bottom is a picture of the system on the benchtop
with two flasks operating.
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depending on the composition of the gas mixture used. The suspension cultures
are maintained by low speed stir plates (VWR) with triangular stir bars for gentle
mixing and temperature is regulated by placing the culture flasks in an in-house
fabricated Plexi-glass water bath with a circulating heating pump set to 37°C
(placed on top of the magnetic stir plates). For the studies reported here, gas flow
into the flasks is supplied by either a 5%CO2 BAL-AIR (normoxia) cylinder or by a
5%CO2/95%N2 cylinder (anoxia) (Argyle) that is connected with tubing to a flow
meter (VWR). After the flow meter, the gas is humidified by passing through a
water bubbler, also sitting in the water bath, followed by passage through an inline flow filter and circulation into the culture flasks (Figure 6.10). The system has
been designed to operate 8 culture flasks in parallel using an in-house fabricated
gas manifold constructed from tubing tee-connectors and is easily controlled by
changing the orientation of the manifold or by simply using hose-clamps to regulate
the gas flow. Finally, before an experiment begins a sterile environment for cell
culturing in the bioreactor flasks is created by autoclaving the entire bioreactor
apparatus including assembled flasks with tubing, syringes, needles, stir-bars, and
tubing adaptors, which makes using autoclavable components essential to the
design considerations.
The media formulations have been the most challenging aspect of
implementing these altered environment experiments. Initially, complete cell
culture media with an extra synthetic buffer added in moderate concentration was
used to produce two pH environments using 25 mM HEPES for pH 7.4/neutral
experiments and 25 mM MES for pH 6.4/acidic experiments. These two media
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groups were adjusted to the desired pH after the addition of the buffer under
ambient gas conditions (i.e. open to the air). However, as described below, a
complicating factor is that CO2 gas flow in combination with the sodium bicarbonate
buffer system interacts with the other added buffers, in some cases leading to
subsequent changes in pH. In the above case, the 250 mL volumes of the
respective neutral or acidic media were added to two 500 mL culture flasks
assembled for gas flow and allowed to sit under gas flow for 12 hours. After this
time, cells were added as follows. A549 WT cells were encapsulated into droplets
using 50 µm hybrid nozzle centrifuge tube assemblies operated at 1100 RPM
(detailed description in Chapter 5). The cell encapsulating droplets were washed
and resuspended into 10 mL of media from the preequilibrated flasks using the
sampling line and then injected into the culture flasks to establish normoxic/neutral
and normoxic/acidic altered environment conditions. The t0 initial droplet
population was imaged using brightfield microscopy and measured by ImageJ
analysis to have a geometric mean diameter of 222 µm, 2%CV. Samples were
taken from each culture flask at 10 hours and after 24 hours the experiments were
terminated. At the 24-hour end point, some precipitates had formed in both culture
conditions and the pH of each culture was remeasured and found to have drifted
(Figure 6.11). After further investigation into the sodium bicarbonate buffering
system, it was found that there is an equilibrium interaction between the sodium
bicarbonate and the added pH buffers. In the case of the normoxic/acidic condition,
which showed a larger shift in pH after 24-hour from 6.4 to 6.8, the concentration
of bicarbonate ion in the cell growth media interacting with 5% CO2 gas, over time,
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Figure 6.11 Preliminary Altered Environments Results. Microscopy of A548
WT cells encapsulated by centrifugal droplet generation and grown in altered
environment suspension culture for 24 hours. The left image shows the droplets
immediately after generation. The middle and right show the droplets sampled
from normoxic/neutral conditions (top) and normoxic/acidic conditions (bottom)
over 10 hour and 24 hours. After 24 hours in culture it appears that the pH was
slightly destabilized due to the sodium bicarbonate buffering system interacting
with the additional synthetic pH buffers added to the media. In addition, some
precipitates were apparent, believed to be due to the interaction of the
bicarbonate/carbonate equilibrium interacting with Ca2+ ions leached out of the
crosslinked alginate droplets.
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leads to a substantial modification of the pH away from the originally established
value of 6.4. This likely occurred because the initial media was pH adjusted under
ambient conditions and not under gas flow. In the long run, and as discussed
below, the more problematic matter is the formation of precipitates that were
observed to form after 24 hours in culture with the calcium alginate droplets. These
are

hypothesized

to

be

caused

by

an

interaction

of

the

carbonic

acid/bicarbonate/carbonate buffer system with calcium ions, where, depending on
pH and added bicarbonate concentration, the formation of very insoluble calcium
carbonate is possible. In this case, the source of the calcium ions is likely the crosslinked calcium alginate, as described below.
The shift in pH and formation of precipitates in the media motivated an
investigation into using powdered media (MEM with L-glutamine, Sigma Aldrich)
without sodium bicarbonate to create complete media solutions with better
equilibrated buffering systems. These media were prepared by dissolving 11g/L of
the powdered media into 1 L of Millipore water with 26 mM sodium bicarbonate
and 25 mM HEPES for the neutral formulation adjusted to pH 7.4 and 2.6 mM
sodium bicarbonate with 25 mM MES for the acidic formulation adjusted to pH 6.4
(all media sterilized by 0.2 µm filtering through a Nalgene bottle top filter
assembly). In both cases, the bicarbonate concentration was chosen to provide
optimal buffering at pH values matching the desired 7.4 or 6.4, respectively. The 4
culture flasks were equilibrated for 12 hours under humidified normoxic gas flow
and in the water bath. This time, A549 WT and KO cells were encapsulated as
before and processed for suspension into their respective altered environmental
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conditions as follows: WT and KO each in normoxic/neutral flasks as well as WT
and KO each in normoxic/acidic flasks. The cell encapsulating droplets were
injected into the culture flasks and sampled after 12 hours. The pH remained stable
under these conditions. However, at that time, the media in all groups was found
to have developed a striking cloudy white consistency, so in this group of
experiments 12 hours became the end point. Samples were observed by bright
field microscopy and found to contain distinct crystalline structures, with essentially
complete disintegration of the alginate droplets. A likely explanation is the
interaction of calcium ions initially localized in the cell encapsulating droplets with
carbonate ions to form insoluble calcium carbonate precipitate, but the detailed
chemistry involved and the dependence of these observations on the presence of
continuously flowing CO2 or specific growth media composition is a matter of
ongoing investigation. For future experiments and for the standardization of 3D
culture environments, particularly for those under altered culture conditions, it is
paramount to have a comprehensive understanding of all cell culture conditions,
including media formulations, incubation environments and buffering systems.
Once a comprehensive system is implemented, it will then be feasible to
investigate the interacting parameters such as those suggested by our exemplary
biomedical question concerning HIF-1α, hypoxia, and acidosis.
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6.5

Discussion and Future Directions
This chapter explored the design and implementation of standardized 3D

culture methodology and applications that are enabled by the technical ability to
generate large populations of controlled cell encapsulating droplets. Growth
assays on two model cell lines with a HIF-1α WT and KO phenotype were
completed as reference experiments for using growth curves and fluorescence
dilution curves to measure proliferation rates in mono and cocultures. The
adaptation of 2D cell culture growth assays to 3D mono and cocultures was
validated by proof-of-principle studies that demonstrated: (1) qualitatively
measured growth of A549 WT and KO cells encapsulated at initial low cell
occupancy over 7 days in suspension culture and (2) the ability to adapt a
membrane fluorescence dilution assay to a 3D coculture by recovering cells from
encapsulating droplets and conducting a two-color fluorescence assay by flow
cytometry to measure and differentiate two populations of cells from the same
coculture. Cells were also encapsulated at high cell occupancy to produce instant
spheroids and were demonstrated to be viable in standard suspension culture
conditions for 7 days. Finally, steps toward creating a 3D cell culture system with
controlled altered environments was designed and implemented. The interaction
between the media and atmospheric conditions required for creating altered
environmental conditions for 3D cell culture is in progress and once complete, will
make a significant contribution to multidisciplinary fields interested in creating
culture conditions that are more realistic for modeling the chemical tumor
microenvironment.
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Chapter 7

Conclusion of the Dissertation
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7.1

Concluding Remarks for the Dissertation
The over-arching motivation of this dissertation is that improvement in 3D

cell culture methods by cell encapsulation in droplets will enable more controllable
and realistic investigations of the heterogeneous environments in which cancer
develops. Each chapter has contributed to the investigation of this high-level
theme. Robust technological developments have been established for the
generation of droplets encapsulating cells and steps toward realizing and
implementing what is needed to create more realistic cell culture conditions have
been discussed. The following Specific Aims have been achieved:
Specific Aim 1: Development and implementation of droplet generation
technologies for cell encapsulation
Droplet generating instrumentation and methodology has been developed
and demonstrated to encapsulate cells for 3D cell culture through the design and
implementation of three droplet generating platforms.
High-throughput droplet generation in the air was addressed in Chapter 3.
The work in Chapter 3 focused on the design and implementation of
instrumentation built from the bottom-up to generate droplets at high rates with
highly optimized device parameters for two different device designs (dual and
single

channel

device

arrangements).

Biocompatible

chemistries

were

investigated using straight alginate gelation as well as water-in-water aqueous twophase separation chemistry (ALG/PEG-in-DEX/Ca2+). Two collection mechanisms
were implemented and characterized, those being droplet collection in a stirring
collection solution and by rigid body rotation, the latter of which is novel and shows
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great promise for future experimentation. Although the instrumentation platforms
designed in Chapter 3 demonstrated droplet generation using highly viscous fluids,
flow and modulation rates, and sizes in the air that have yet to be observed when
using other methods with similar sized nozzles, the challenge of collecting perfectly
spherical particles with encapsulated cells was not fully overcome because of the
high-speed generation rate of droplets in all of the design iterations and collection
mechanisms investigated. However, there were still technical advancements made
and all of the expertise and knowledge gained enabled the designs, technology
implementation, and results presented in the subsequent chapters. Finally, some
advancements have been made with the further characterization of the aqueous
two-phase separation chemistry (detailed in Chapter 4) that is hypothesized to
enhance the sphericity in collection of high-throughput acoustically generated
droplets and possibly enable cell encapsulation using this platform.
Microfluidic droplet generation using acoustics and redesigned aqueous
two-phase separation chemistries is addressed in Chapter 4. The work in Chapter
4 was a highly collaborative effort that focused on the encapsulation of cells by
generating water-in-water droplets in a microfluidics device where the break-up of
the immiscible flow streams within the device was modulated by a speaker. The
aqueous two-phase separation chemistry was investigated further and an
improved protocol for preparing enriched solutions of phase separated PEG and
DEX was developed. These enriched polymer solutions (characterized and
validated with rheology and index of refraction investigations) were then used in
the microfluidics device with speaker modulation to optimize the system for flow
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rate and frequency combinations that produced monodispersed populations of
droplets both with and without cells. The system was then used to demonstrate the
encapsulation of EMT6 mouse mammary carcinoma cells and suspension culture
over 9 days, using a robust protocol developed to initially make a single cell
suspension within a highly viscous biomaterial and validated to be a biocompatible
approach by LIVE/DEAD assay. Cell proliferation within the droplets was observed
with microscopy of the droplets at time points over the 9-day interval and the
method was demonstrated to be a robust and viable technology to encapsulate
and culture cells in 3D.
Centrifugal droplet generation for mass production of cell encapsulating
droplets is presented in Chapter 5. The work in Chapter 5 expands the application
space of preexisting centrifugal tube assembly methodology for droplet generation
by implementing the design and construction of hybrid glass capillary/needle
nozzles to control the diameter of the nozzle that ultimately influences the droplet
diameter of the population produced. This improved droplet generation method is
validated and optimized by investigating the artificial gravity under which the
droplets are generated using the smallest gauge needle in comparison to hybrid
(glass capillary/needle) nozzles, which have a radius of nearly half that of the
commercially available needles. Improved droplet generation was demonstrated
by measuring the populations of droplets generated over a range of centrifugal
forces with both types of nozzles and showing that the hybrid nozzle enabled
smaller sized and monodispersed droplet populations under equivalent generation
conditions. The generation of cell-sized droplets using a hybrid nozzle with a small
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(5-7 µm) diameter nozzle was investigated and demonstrated the new ability to
generate alginate droplets down to a size range of 25-40 µm diameter. These
droplets that are produced with a size on order of a large cell are a highly desirable
platform for applications in cell-free systems such as the stabilization of vesicles,
proteins,

and

other

biomolecules

outside

the

context

of

cellular

compartmentalization. Centrifugal droplet generation using the hybrid nozzle was
demonstrated to be a viable technology for the encapsulation of a range of cell
types and concentrations. This centrifugal droplet formation technology became
the preferred method of generation for the development of biological assays in
Chapter 6 because of the reproducibility in device operation, high-throughput mode
of droplet generation, adaptability to any desired format of cell encapsulation for
3D culture, and the strikingly monodisperse droplet populations produced.
Specific Aim 2: Development of standardized biological assays to measure
droplet-based 3D cell cultures
Chapter 6 demonstrated the development of cancer research applications to
measure qualities of cells that have been encapsulated and grown (using the
approaches described in Specific Aim 1). Chapter 6 presents the development,
implementation, and in some instances challenges of creating standardized
biological assays for 3D cell culture. Proliferation assays in 2D and proof-ofprinciple adaptation to 3D cell mono- and co-cultures was presented and
demonstrates a feasible method of measuring cell growth for multiple cell types.
The growth and fluorescence dilution assays establish improved 3D cell culture
protocols that have a high probability of easily being adapted into standard lab
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practices and in more complex 3D constructs. The formation of multicellular tumor
spheroids either instantly by initial high cell loading in droplets or over time with
initial low cell loading was demonstrated using droplet generation methods
established in Chapters 4 and 5. Finally, a 3D suspension culture system with
altered biochemical microenvironments was built and the validation process is
currently under way. In addition, the implementation of this new technology is
discussed in the context of the cancer research question posed in Chapter 1
involving the HIF-1α mediated responses to both coupled and uncoupled
variations of hypoxia and acidosis. Evaluating the technology and assay
development presented in this dissertation through the lens of a relevant and
currently unanswered multiparametric cancer research hypothesis provides a
compelling reason for the overall effort.
In summary, Specific Aim 1 was successfully accomplished through the
improvement and advancement in droplet generating technologies for cell
encapsulation. The three droplet generation platforms described in Chapters 3, 4,
and 5 make advancements in multidisciplinary fields. The knowledge gained by
the individual dynamics investigated in each droplet generation method will enable
the continued development of improved cell encapsulation strategies. Specific Aim
2 was accomplished by generation of viable 3D constructs and measurement
techniques for use in advanced cell culture systems. The findings presented in this
dissertation have implications for the future development of 3D cell culture in terms
of overall cost, high throughput operation, monodispersity, biocompatibility, and
widespread implementation of the technology.
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